{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:22:01Z","timestamp":1783527721081,"version":"3.55.0"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"DOI":"10.7759\/cureus.112280","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:48:34Z","timestamp":1783525714000},"source":"Crossref","is-referenced-by-count":0,"title":["A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023"],"prefix":"10.7759","author":[{"given":"Natalia","family":"Maverakis Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary J","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.09.008","article-title":"Update on the pathogenesis of vitiligo","volume":"97","author":"Marchioro HZ","year":"2022","unstructured":"Marchioro HZ, de Castro CCS, Fava VM, Sakiyama PH, Dellatorre G, Miot HA. Update on the pathogenesis of vitiligo. An Bras Dermatol. 2022, 97:478-490. 10.1016\/j.abd.2021.09.008","journal-title":"An Bras Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.2162","article-title":"Incidence and prevalence of diagnosed vitiligo according to race and ethnicity, age, and sex in the US","volume":"159","author":"Mastacouris N","year":"2023","unstructured":"Mastacouris N, Strunk A, Garg A. Incidence and prevalence of diagnosed vitiligo according to race and ethnicity, age, and sex in the US. JAMA Dermatol. 2023, 159:986-990. 10.1001\/jamadermatol.2023.2162","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kruger C","year":"2012","unstructured":"Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children\/adolescents and adults. Int J Dermatol. 2012, 51:1206-1212. 10.1111\/j.1365-4632.2011.05377.x","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01165-5","article-title":"Patient burden of nonsegmental vitiligo: a US real-world survey of dermatologists and their patients","volume":"14","author":"Rosmarin D","year":"2024","unstructured":"Rosmarin D, Lofland JH, Marwaha S, Piercy J, Anderson P, Liu J. Patient burden of nonsegmental vitiligo: a US real-world survey of dermatologists and their patients. Dermatol Ther. 2024, 14:1531-1546. 10.1007\/s13555-024-01165-5","journal-title":"Dermatol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003263.pub5","article-title":"Interventions for vitiligo","volume":"2015","author":"Whitton ME","year":"2015","unstructured":"Whitton ME, Pinart M, Batchelor J, et al.. Interventions for vitiligo. Cochrane Database Syst Rev. 2015, 2015:003263. 10.1002\/14651858.CD003263.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022, 18:","journal-title":"Campbell Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12619","article-title":"Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: a randomized, single-blind comparison study","volume":"37","author":"Poolsuwan P","year":"2021","unstructured":"Poolsuwan P, Churee C, Pattamadilok B. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: a randomized, single-blind comparison study. Photodermatol Photoimmunol Photomed. 2021, 37:123-130. 10.1111\/phpp.12619","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S260434","article-title":"308-nm excimer laser plus platelet-rich plasma for treatment of stable vitiligo: A prospective, randomized case-control study","volume":"13","author":"Deng Y","year":"2020","unstructured":"Deng Y, Li J, Yang G. 308-nm excimer laser plus platelet-rich plasma for treatment of stable vitiligo: A prospective, randomized case-control study. Clin Cosmet Investig Dermatol. 2020, 13:461-467. 10.2147\/CCID.S260434","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13103","article-title":"Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study","volume":"19","author":"Khattab FM","year":"2020","unstructured":"Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study. J Cosmet Dermatol. 2020, 19:869-877. 10.1111\/jocd.13103","journal-title":"J Cosmet Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12747","article-title":"A preliminary study of fractional CO(2) laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo","volume":"32","author":"Wen X","year":"2019","unstructured":"Wen X, Hamblin MR, Xian Y, Li Y. A preliminary study of fractional CO(2) laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo. Dermatol Ther. 2019, 32:12747. 10.1111\/dth.12747","journal-title":"Dermatol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12784","article-title":"Maintenance phototherapy for vitiligo: a multicenter, randomized controlled trial","volume":"38","author":"Ju HJ","year":"2022","unstructured":"Ju HJ, Lee RW, Park S, et al.. Maintenance phototherapy for vitiligo: a multicenter, randomized controlled trial. Photodermatol Photoimmunol Photomed. 2022, 38:608-610. 10.1111\/phpp.12784","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14080","article-title":"The value of adding platelet-rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: a self-controlled randomised double-blinded study","volume":"64","author":"Abdel Halim DM","year":"2023","unstructured":"Abdel Halim DM, Fekry A, Mogawer RM. The value of adding platelet-rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: a self-controlled randomised double-blinded study. Aust J Dermatol. 2023, 64:359-367. 10.1111\/ajd.14080","journal-title":"Aust J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13056","article-title":"Improvement in moderate to severe vitiligo using a novel combination of 308 nm excimer laser and a surgical needling technique","volume":"42","author":"BinSheikhan S","year":"2017","unstructured":"BinSheikhan S, Al Abadie M. Improvement in moderate to severe vitiligo using a novel combination of 308 nm excimer laser and a surgical needling technique. Clin Exp Dermatol. 2017, 42:363-366. 10.1111\/ced.13056","journal-title":"Clin Exp Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00395-7","article-title":"Electrocautery needling and the 308-nm excimer lamp: a synergistic combination for the treatment of stable non-segmental vitiligo","volume":"10","author":"Yang L","year":"2020","unstructured":"Yang L, Wong PM, Katayama I, Wu H, Zhang H. Electrocautery needling and the 308-nm excimer lamp: a synergistic combination for the treatment of stable non-segmental vitiligo. Dermatol Ther. 2020, 10:695-705. 10.1007\/s13555-020-00395-7","journal-title":"Dermatol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17630","article-title":"A multicentre, randomized, split face and\/or neck comparison of 308-nm excimer laser and 0\u00b71% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo","volume":"181","author":"Wu Y","year":"2019","unstructured":"Wu Y, Sun Y, Qiu L, et al.. A multicentre, randomized, split face and\/or neck comparison of 308-nm excimer laser and 0\u00b71% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo. Br J Dermatol. 2019, 181:210-211. 10.1111\/bjd.17630","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12289","article-title":"Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study","volume":"28","author":"Abdel Latif AA","year":"2015","unstructured":"Abdel Latif AA, Ibrahim SMA. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study. Dermatol Ther. 2015, 28:383-389. 10.1111\/dth.12289","journal-title":"Dermatol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.03.009","article-title":"Suberythemic and erythemic doses of a 308-nm excimer laser treatment of stable vitiligo in combination with topical tacrolimus: a randomized controlled trial","volume":"83","author":"Bae JM","year":"2020","unstructured":"Bae JM, Kwon SH, Ju HJ, Kang HY. Suberythemic and erythemic doses of a 308-nm excimer laser treatment of stable vitiligo in combination with topical tacrolimus: a randomized controlled trial. J Am Acad Dermatol. 2020, 83:1463-1464. 10.1016\/j.jaad.2020.03.009","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-020-03048-5","article-title":"Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study","volume":"35","author":"Juntongjin P","year":"2020","unstructured":"Juntongjin P, Toncharoenphong N. Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study. Lasers Med Sci. 2020, 35:2023-2029. 10.1007\/s10103-020-03048-5","journal-title":"Lasers Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14886","article-title":"Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: a randomized double-blind comparative study","volume":"34","author":"Juntongjin P","year":"2021","unstructured":"Juntongjin P, Sangganjanavanich P. Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: a randomized double-blind comparative study. Dermatol Ther. 2021, 34:e14886. 10.1111\/dth.14886","journal-title":"Dermatol Ther"},{"key":"ref20","article-title":"Effect of an antioxydant cream versus placebo in patients with vitiligo in association with excimer laser. A pilot randomized, investigator-blinded, and half-side comparison trial","volume":"150","author":"Leone G","year":"2015","unstructured":"Leone G, Vidolin AP. Effect of an antioxydant cream versus placebo in patients with vitiligo in association with excimer laser. A pilot randomized, investigator-blinded, and half-side comparison trial. G Ital Dermatol Venereol. 2015, 150:461-466.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12883","article-title":"The effectiveness of combination therapy with 308-nm excimer laser in vitiligo in Han Chinese People","volume":"60","author":"Li L","year":"2019","unstructured":"Li L, Hong J, Lan L, et al.. The effectiveness of combination therapy with 308-nm excimer laser in vitiligo in Han Chinese People. Austral J Dermatol. 2019, 60:85-86. 10.1111\/ajd.12883","journal-title":"Austral J Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13726","article-title":"The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients","volume":"36","author":"Li L","year":"2019","unstructured":"Li L, Liang Y, Hong J, Lan L, Xiao H, Xie Z. The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients. Pediatr Dermatol. 2019, 36:53-55. 10.1111\/pde.13726","journal-title":"Pediatr Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1052510","article-title":"Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo","volume":"18","author":"Soliman M","year":"2016","unstructured":"Soliman M, Samy NA, Abo Eittah M, Hegazy M. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo. J Cosmet Laser Ther. 2016, 18:7-11. 10.3109\/14764172.2015.1052510","journal-title":"J Cosmet Laser Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.09.048","article-title":"Comparison of cyclic and continuous 308-nm excimer laser treatments for vitiligo: a randomized controlled noninferiority trial","volume":"78","author":"Sung JM","year":"2018","unstructured":"Sung JM, Bae JM, Kang HY. Comparison of cyclic and continuous 308-nm excimer laser treatments for vitiligo: a randomized controlled noninferiority trial. J Am Acad Dermatol. 2018, 78:605-607. 10.1016\/j.jaad.2017.09.048","journal-title":"J Am Acad Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12820","article-title":"Intradermal injection of fluorouracil versus triamcinolone in localized vitiligo treatment","volume":"18","author":"Zohdy HAEW","year":"2019","unstructured":"Zohdy HAEW, Hussein MS. Intradermal injection of fluorouracil versus triamcinolone in localized vitiligo treatment. J Cosmet Dermatol. 2019, 18:1430-1434. 10.1111\/jocd.12820","journal-title":"J Cosmet Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14738","article-title":"Effect of platelet-rich plasma on the outcome of mini-punch grafting procedure in localized stable vitiligo: clinical evaluation and relation to lesional basic fibroblast growth factor","volume":"34","author":"Salem SAM","year":"2021","unstructured":"Salem SAM, Fezeaa TA, El Khazragy N, Soltan MY. Effect of platelet-rich plasma on the outcome of mini-punch grafting procedure in localized stable vitiligo: clinical evaluation and relation to lesional basic fibroblast growth factor. Dermatol Ther. 2021, 34:e14738. 10.1111\/dth.14738","journal-title":"Dermatol Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12397","article-title":"Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial","volume":"17","author":"Abdelghani R","year":"2018","unstructured":"Abdelghani R, Ahmed NA, Darwish HM. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial. J Cosmet Dermatol. 2018, 17:365-372. 10.1111\/jocd.12397","journal-title":"J Cosmet Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S178817","article-title":"Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study","volume":"11","author":"Kadry M","year":"2018","unstructured":"Kadry M, Tawfik A, Abdallah N, Badawi A, Shokeir H. Platelet-rich plasma versus combined fractional carbon dioxide laser with platelet-rich plasma in the treatment of vitiligo: a comparative study. Clin Cosmet Investig Dermatol. 2018, 11:551-559. 10.2147\/CCID.S178817","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-020-03195-9","article-title":"Fractional CO2 laser, platelet rich plasma and narrow band ultraviolet B in the treatment of Vitiligo (a randomized clinical trial)","volume":"36","author":"Afify AA","year":"2021","unstructured":"Afify AA, Zuelfakkar NM, Eshafi MA. Fractional CO2 laser, platelet rich plasma and narrow band ultraviolet B in the treatment of Vitiligo (a randomized clinical trial). Lasers Med Sci. 2021, 36:1479-1486. 10.1007\/s10103-020-03195-9","journal-title":"Lasers Med Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-023-02700-8","article-title":"Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo","volume":"315","author":"Neinaa YMEH","year":"2023","unstructured":"Neinaa YMEH, Mahmoud MAE, El Maghraby GM, Ibrahim ZAE. Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo. Arch Dermatol Res. 2023, 315:2647-2653. 10.1007\/s00403-023-02700-8","journal-title":"Arch Dermatol Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15577","article-title":"Platelet-rich plasma and follicular transplantation versus follicular transplantation alone in the treatment of refractory vitiligo: a comparative pilot study","volume":"35","author":"Feily A","year":"2022","unstructured":"Feily A, Seifi V, Parvar SY, et al.. Platelet-rich plasma and follicular transplantation versus follicular transplantation alone in the treatment of refractory vitiligo: a comparative pilot study. Dermatol Ther. 2022, 35:e15577. 10.1111\/dth.15577","journal-title":"Dermatol Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/jewd.jewd_1_23","article-title":"Platelet-rich plasma versus microneedling effects in NB-UVB non-responder vitiligo patients","volume":"20","author":"Khalil KT","year":"2023","unstructured":"Khalil KT, Ibrahim SE. Platelet-rich plasma versus microneedling effects in NB-UVB non-responder vitiligo patients. J Egyptian Women's Dermatol Soc. 2023, 20:114-119. 10.4103\/jewd.jewd_1_23","journal-title":"J Egyptian Women's Dermatol Soc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14324","article-title":"Fractional versus full ablative CO2 laser in recipient site of non-cultured melanocytes and keratinocyte transplantation in treatment of vitiligo","volume":"21","author":"Jamal-edine AM","year":"2022","unstructured":"Jamal-edine AM, El-Barbary RA, Moftah NH. Fractional versus full ablative CO2 laser in recipient site of non-cultured melanocytes and keratinocyte transplantation in treatment of vitiligo. J Cosmet Dermatol. 2022, 21:1506-1513. 10.1111\/jocd.14324","journal-title":"J Cosmet Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-017-2290-y","article-title":"Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo","volume":"32","author":"El-Zawahry MB","year":"2017","unstructured":"El-Zawahry MB, Zaki NS, Wissa MY, Saleh MA. Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo. Lasers Med Sci. 2017, 32:1953-1958. 10.1007\/s10103-017-2290-y","journal-title":"Lasers Med Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1564232","article-title":"Evaluation of using fractional CO2 laser plus NB-UVB versus NB-UVB alone in inducing marginal repigmentation of vitiligo lesions","volume":"30","author":"Ghasemloo S","year":"2019","unstructured":"Ghasemloo S, Gauthier Y, Ghalamkarpour F. Evaluation of using fractional CO2 laser plus NB-UVB versus NB-UVB alone in inducing marginal repigmentation of vitiligo lesions. J Dermatol Treat. 2019, 30:697-700. 10.1080\/09546634.2018.1564232","journal-title":"J Dermatol Treat"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001890","article-title":"No additional benefit of combining fractional carbon dioxide laser with narrow-band ultraviolet B phototherapy for vitiligo: a randomized prospective study with half-body side comparison","volume":"45","author":"E\u015fme P","year":"2019","unstructured":"E\u015fme P, Aksoy GG, El\u00e7in G. No additional benefit of combining fractional carbon dioxide laser with narrow-band ultraviolet B phototherapy for vitiligo: a randomized prospective study with half-body side comparison. Dermatol Surg. 2019, 45:1627-1634. 10.1097\/DSS.0000000000001890","journal-title":"Dermatol Surg"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15396","article-title":"Beneficial UVB phototherapy preceding a fractional CO2 laser-UVB protocol in refractory non-segmental vitiligo","volume":"21","author":"Helou J","year":"2022","unstructured":"Helou J, Soutou B, Maatouk I, et al.. Beneficial UVB phototherapy preceding a fractional CO2 laser-UVB protocol in refractory non-segmental vitiligo. J Cosmet Dermatol. 2022, 21:6783-6787. 10.1111\/jocd.15396","journal-title":"J Cosmet Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000844","article-title":"Fractional CO2 laser pretreatment to autologous hair transplantation and phototherapy improves perifollicular repigmentation in refractory vitiligo: a randomized, prospective, half-lesion, comparative study","volume":"42","author":"Feily A","year":"2016","unstructured":"Feily A, Seifi V, Ramirez-Fort MK. Fractional CO2 laser pretreatment to autologous hair transplantation and phototherapy improves perifollicular repigmentation in refractory vitiligo: a randomized, prospective, half-lesion, comparative study. Dermatol Surg. 2016, 42:1082-1088. 10.1097\/DSS.0000000000000844","journal-title":"Dermatol Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0299","article-title":"Efficacy of autologous melanocyte transplantation on amniotic membrane in patients with stable leukoderma: a randomized clinical trial","volume":"151","author":"Redondo P","year":"2015","unstructured":"Redondo P, De Azcarate AG, N\u00fa\u00f1ez-C\u00f3rdoba JM, et al.. Efficacy of autologous melanocyte transplantation on amniotic membrane in patients with stable leukoderma: a randomized clinical trial. JAMA Dermatol. 2015, 151:897-899. 10.1001\/jamadermatol.2015.0299","journal-title":"JAMA Dermatol"},{"key":"ref40","article-title":"Efficacy of fractional CO2 laser, NB-UVB and 0.05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: a comparative study","volume":"9","author":"Choudhary M","year":"2022","unstructured":"Choudhary M, Kothiwala R. Efficacy of fractional CO2 laser, NB-UVB and 0.05% clobetasol propionate vs NB-UVB and .05% clobetasol propionate in patients with vitiligo: a comparative study. Eur J Mol Clin Med. 2022, 9:1027-1031.","journal-title":"Eur J Mol Clin Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1509048","article-title":"Ablative fractional Co2 laser aided delivery of long-acting glucocorticoid in the treatment of acral vitiligo: a multicenter, prospective, self-bilateral controlled study","volume":"30","author":"Liu L","year":"2019","unstructured":"Liu L, Wu Y, Zhang J, et al.. Ablative fractional Co2 laser aided delivery of long-acting glucocorticoid in the treatment of acral vitiligo: a multicenter, prospective, self-bilateral controlled study. J Dermatol Treat. 2019, 30:320-327. 10.1080\/09546634.2018.1509048","journal-title":"J Dermatol Treat"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22389","article-title":"Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas","volume":"48","author":"Vachiramon V","year":"2016","unstructured":"Vachiramon V, Chaiyabutr C, Rattanaumpawan P, Kanokrungsee S. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas. Lasers in Surgery and Medicine. 2016, 48:197-202. 10.1002\/lsm.22389","journal-title":"Lasers in Surgery and Medicine"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2022.101684","article-title":"Investigation of optimal energy or density of a fractional CO2 laser system in the treatment of stable non-segmental vitiligo","volume":"49","author":"Yuan J","year":"2022","unstructured":"Yuan J, Lu Y, Wu Y, Gao XH, Chen HD. Investigation of optimal energy or density of a fractional CO2 laser system in the treatment of stable non-segmental vitiligo. Complement Ther Clin Pract. 2022, 49:101684. 10.1016\/j.ctcp.2022.101684","journal-title":"Complement Ther Clin Pract"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13134","article-title":"Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy","volume":"19","author":"Doghaim NN","year":"2020","unstructured":"Doghaim NN, El-Tatawy RA, Ismail MA, Ali DAM, El Attar YA. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy. J Cosmet Dermatol. 2020, 19:122-130. 10.1111\/jocd.13134","journal-title":"J Cosmet Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-016-1982-z","article-title":"A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo","volume":"31","author":"Kanokrungsee S","year":"2016","unstructured":"Kanokrungsee S, Chanprapaph K, Chaiyabutr C, Vachiramon V. A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo. Lasers Med Sci. 2016, 31:1343-1349. 10.1007\/s10103-016-1982-z","journal-title":"Lasers Med Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15198","article-title":"Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: a randomized half-body, double-blind, placebo-controlled, comparative study","volume":"35","author":"Kanokrungsee S","year":"2022","unstructured":"Kanokrungsee S, Khunkhet S, Rojhirunsakool S, Thadvibun K, Sahaspot T. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: a randomized half-body, double-blind, placebo-controlled, comparative study. Dermatol Ther. 2022, 35:10.1111\/dth.15198","journal-title":"Dermatol Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12202","article-title":"Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study","volume":"28","author":"Li L","year":"2015","unstructured":"Li L, Wu Y, Sun Y, Qiu L, Gao XH, Chen HD. Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study. Dermatol Ther. 2015, 28:131-134. 10.1111\/dth.12202","journal-title":"Dermatol Ther"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17464","article-title":"Comparison of microneedling and full surface erbium laser dermabrasion for autologous cell suspension grafting in nonsegmental vitiligo: a randomized controlled trial","volume":"180","author":"Lagrange S","year":"2019","unstructured":"Lagrange S, Montaudi\u00e9 H, Fontas E, Bahadoran P, Lacour JP, Passeron T. Comparison of microneedling and full surface erbium laser dermabrasion for autologous cell suspension grafting in nonsegmental vitiligo: a randomized controlled trial. Brit J Dermatol. 2019, 180:1539-1540. 10.1111\/bjd.17464","journal-title":"Brit J Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519871382","article-title":"Effect of vitiligo treatment using compound glycyrrhizin combined with fractional carbon dioxide laser and topical triamcinolone acetonide on serum interleukin-17 and tissue growth factor- \u03b2 levels","volume":"47","author":"Li L","year":"2019","unstructured":"Li L, Ma Q, Li H. Effect of vitiligo treatment using compound glycyrrhizin combined with fractional carbon dioxide laser and topical triamcinolone acetonide on serum interleukin-17 and tissue growth factor- \u03b2 levels. J Int Med Res. 2019, 47:5623-5631. 10.1177\/0300060519871382","journal-title":"J Int Med Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12512","article-title":"A comparative clinical trial to evaluate efficacy and safety of the 308-nm excimer laser and the gain-switched 311-nm titanium:sapphire laser in the treatment of vitiligo","volume":"36","author":"Park MJ","year":"2020","unstructured":"Park MJ, Shon U, Seong GH, Kim MH, Park BC, Hong SP. A comparative clinical trial to evaluate efficacy and safety of the 308-nm excimer laser and the gain-switched 311-nm titanium:sapphire laser in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2020, 36:97-104. 10.1111\/phpp.12512","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.4103\/JEWD.JEWD_41_19","article-title":"The efficacy of combining fractional CO2 laser and tacrolimus ointment in the treatment of vitiligo","volume":"17","author":"Abu Zeid O","year":"2020","unstructured":"Abu Zeid O, Omar N, El Sharkawy D. The efficacy of combining fractional CO2 laser and tacrolimus ointment in the treatment of vitiligo. J Egypt Women's Dermatol Soc. 2020, 17:25-30. 10.4103\/JEWD.JEWD_41_19","journal-title":"J Egypt Women's Dermatol Soc"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S225881","article-title":"Effect of topical 5-fluorouracil alone versus its combination with erbium:YAG (2940 nm) laser in treatment of vitiligo","volume":"13","author":"Abdelwahab M","year":"2020","unstructured":"Abdelwahab M, Salah M, Samy N, Rabie A, Farrag A. Effect of topical 5-fluorouracil alone versus its combination with erbium:YAG (2940 nm) laser in treatment of vitiligo. Clin Cosmet Investig Dermatol. 2020, 13:77-85. 10.2147\/CCID.S225881","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23048","article-title":"Comparison of 311-nm titanium:sapphire laser and 308-nm excimer laser treatment for vitiligo: a randomized controlled non-inferiority trial","volume":"51","author":"Bae JM","year":"2019","unstructured":"Bae JM, Eun SH, Lee HN, Kim GM, Grimes PE, Lee JH. Comparison of 311-nm titanium:sapphire laser and 308-nm excimer laser treatment for vitiligo: a randomized controlled non-inferiority trial. Lasers Surg Med. 2019, 51:239-244. 10.1002\/lsm.23048","journal-title":"Lasers Surg Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2014.1003241","article-title":"Carbon dioxide laser plus topical 5-fluorouracil: a new combination therapeutic modality for acral vitiligo","volume":"17","author":"Mohamed HA","year":"2015","unstructured":"Mohamed HA, Mohammed GF, Gomaa AHA, Eyada MMK. Carbon dioxide laser plus topical 5-fluorouracil: a new combination therapeutic modality for acral vitiligo. J Cosmet Laser Ther. 2015, 17:216-223. 10.3109\/14764172.2014.1003241","journal-title":"J Cosmet Laser Ther"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12373","article-title":"Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol","volume":"17","author":"Mokhtari F","year":"2018","unstructured":"Mokhtari F, Bostakian A, Shahmoradi Z, et al.. Potential emerging treatment in vitiligo using Er:YAG in combination with 5FU and clobetasol. J Cosmet Dermatol. 2018, 17:165-170. 10.1111\/jocd.12373","journal-title":"J Cosmet Dermatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22821","article-title":"Preliminary study on the treatment of vitiligo with carbon dioxide fractional laser together with tacrolimus","volume":"50","author":"Chen W","year":"2018","unstructured":"Chen W, Zhou Y, Huang FR, Luo D, Wang DG. Preliminary study on the treatment of vitiligo with carbon dioxide fractional laser together with tacrolimus. Lasers Surg Med. 2018, 50:829-836. 10.1002\/lsm.22821","journal-title":"Lasers Surg Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12410","article-title":"New approach in the treatment of refractory vitiligo: CO(2) laser combined with betamethasone and salicylic acid solution","volume":"30","author":"Cunha PR","year":"2017","unstructured":"Cunha PR, Pessotti NS, Mattos CB, Salai AF. New approach in the treatment of refractory vitiligo: CO(2) laser combined with betamethasone and salicylic acid solution. Dermatol Ther. 2017, 30:e12410. 10.1111\/dth.12410","journal-title":"Dermatol Ther"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14648","article-title":"The additive efficacy of therapeutic low-intensity pulsed ultrasound in the treatment of vitiligo: a randomized, left-right comparison clinical trial","volume":"34","author":"Liao YH","year":"2021","unstructured":"Liao YH, Chen WS, Jee SH. The additive efficacy of therapeutic low-intensity pulsed ultrasound in the treatment of vitiligo: a randomized, left-right comparison clinical trial. Dermatol Ther. 2021, 34:e14648. 10.1111\/dth.14648","journal-title":"Dermatol Ther"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13117","article-title":"Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study","volume":"32","author":"Anbar TS","year":"2019","unstructured":"Anbar TS, Mohammed SS, Mohamed DM, Abdel-Rahman AT. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study. Dermatol Ther. 2019, 32:10.1111\/dth.13117","journal-title":"Dermatol Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12495","article-title":"Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: a pilot randomized controlled study","volume":"36","author":"Liu B","year":"2020","unstructured":"Liu B, Sun Y, Song J, Wu Z. Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: a pilot randomized controlled study. Photodermatol Photoimmunol Photomed. 2020, 36:14-20. 10.1111\/phpp.12495","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12061","article-title":"BB-UVA vs. NB-UVB in the treatment of vitiligo: A randomized controlled clinical study (single blinded)","volume":"29","author":"El-Mofty M","year":"2013","unstructured":"El-Mofty M, Mostafa W, Youssef R, et al.. BB-UVA vs. NB-UVB in the treatment of vitiligo: A randomized controlled clinical study (single blinded). Photodermatol Photoimmunol and Photomed. 2013, 29:239-246. 10.1111\/phpp.12061","journal-title":"Photodermatol Photoimmunol and Photomed"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12099","article-title":"Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial","volume":"38","author":"El Mofty M","year":"2013","unstructured":"El Mofty M, Bosseila M, Mashaly HM, Gawdat H, Makaly H. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial. Clin Exp Dermatol. 2013, 38:830-835. 10.1111\/ced.12099","journal-title":"Clin Exp Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-51","article-title":"Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy)","volume":"15","author":"Eleftheriadou V","year":"2014","unstructured":"Eleftheriadou V, Thomas K, Ravenscroft J, Whitton M, Batchelor J, Williams H. Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy). Trials. 2014, 15:51. 10.1186\/1745-6215-15-51","journal-title":"Trials"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.12.026","article-title":"Randomized, parallel group trial comparing home-based phototherapy with institution-based 308 excimer lamp for the treatment of focal vitiligo vulgaris","volume":"72","author":"Guan STT","year":"2015","unstructured":"Guan STT, Theng C, Chang A. Randomized, parallel group trial comparing home-based phototherapy with institution-based 308 excimer lamp for the treatment of focal vitiligo vulgaris. J Am Acad Dermatol. 2015, 72:733-735. 10.1016\/j.jaad.2014.12.026","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14582","article-title":"Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo","volume":"21","author":"Elsaadany AE","year":"2022","unstructured":"Elsaadany AE, El-Khalawany M, Elshahid AR, Abdel-Hameed AKS. Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo. J Cosmet Dermatol. 2022, 21:2826-2831. 10.1111\/jocd.14582","journal-title":"J Cosmet Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15229","article-title":"Combination of carboxytherapy with narrowband-ultraviolet B in the treatment of recalcitrant areas of vitiligo: a randomized clinical trial","volume":"35","author":"Farajzadeh S","year":"2022","unstructured":"Farajzadeh S, Yazdanpanah F, Khalili M, Mohammadi S, Iranmanesh B, Aflatoonian M. Combination of carboxytherapy with narrowband-ultraviolet B in the treatment of recalcitrant areas of vitiligo: a randomized clinical trial. Dermatol Ther. 2022, 35:e15229. 10.1111\/dth.15229","journal-title":"Dermatol Ther"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.054","article-title":"Efficacy of NB-UVB, microneedling with triamcinolone acetonide, and a combination of both modalities in the treatment of vitiligo: a comparative study","volume":"79","author":"Khashaba SAE","year":"2018","unstructured":"Khashaba SAE, Elkot RA, Ibrahim AM. Efficacy of NB-UVB, microneedling with triamcinolone acetonide, and a combination of both modalities in the treatment of vitiligo: a comparative study. J Am Acad Dermatol. 2018, 79:365-367. 10.1016\/j.jaad.2017.12.054","journal-title":"J Am Acad Dermatol"},{"key":"ref68","article-title":"Surrounding needling and narrowband ultraviolet B phototherapy treatment: synergistic effects for repigmentation in chronic, stable nonsegmental vitiligo","volume":"29","author":"Chu GY","year":"2023","unstructured":"Chu GY, Weng SM, Huang CC, Liang WC, Hsu CH. Surrounding needling and narrowband ultraviolet B phototherapy treatment: synergistic effects for repigmentation in chronic, stable nonsegmental vitiligo. Alternative therapies in health and medicine. 2023, 29:96-103.","journal-title":"Alternative therapies in health and medicine"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13312","article-title":"Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: a prospective comparative study","volume":"19","author":"Anbar TS","year":"2020","unstructured":"Anbar TS, El-Ammawi TS, Mohammed SS, Abdel-Rahman AT. Noncultured epidermal suspensions obtained from partial-thickness epidermal cuts and suction blister roofs for vitiligo treatment: a prospective comparative study. J Cosmet Dermatol. 2020, 19:2684-2691. 10.1111\/jocd.13312","journal-title":"J Cosmet Dermatol"},{"key":"ref70","article-title":"Efficacy and tolerability of needling as an adjuvant to narrowband ultraviolet B therapy in the treatment of vitiligo: a clinical trial","volume":"16","author":"Ebadi A","year":"2013","unstructured":"Ebadi A, Moravvej H, Hejazi S, Younespour S, Ghalamkarpour F. Efficacy and tolerability of needling as an adjuvant to narrowband ultraviolet B therapy in the treatment of vitiligo: a clinical trial. Iran J Dermatol. 2013, 16:89-93.","journal-title":"Iran J Dermatol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2062279","article-title":"Evaluation of needling\/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study","volume":"33","author":"Esmat S","year":"2022","unstructured":"Esmat S, Assaf MI, Mohye Eldeen R, Gawdat HI, Saadi DG. Evaluation of needling\/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study. J Dermatol Treat. 2022, 33:2621-2628. 10.1080\/09546634.2022.2062279","journal-title":"J Dermatol Treat"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14286","article-title":"Use of platelet-rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double-blind randomized controlled trial","volume":"58","author":"Parambath N","year":"2019","unstructured":"Parambath N, Sharma VK, Parihar AS, Sahni K, Gupta S. Use of platelet-rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double-blind randomized controlled trial. Int J Dermatol. 2019, 58:472-476. 10.1111\/ijd.14286","journal-title":"Int J Dermatol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_122_21","article-title":"Comparison of smash skin grafting and autologous non-cultured epidermal cell suspension in re-pigmentation of stable vitiligo","volume":"15","author":"Rao KMS","year":"2022","unstructured":"Rao KMS, Koti VR, Gaikwad S. Comparison of smash skin grafting and autologous non-cultured epidermal cell suspension in re-pigmentation of stable vitiligo. J Cutan Aesthet Surg. 2022, 15:288-294. 10.4103\/JCAS.JCAS_122_21","journal-title":"J Cutan Aesthet Surg"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000002329","article-title":"Effect of different methods of trypsinization on cell viability and clinical outcome in vitiligo patients undergoing noncultured epidermal cellular suspension","volume":"46","author":"Rasheed HM","year":"2020","unstructured":"Rasheed HM, Esmat SM, Hegazy RA, et al.. Effect of different methods of trypsinization on cell viability and clinical outcome in vitiligo patients undergoing noncultured epidermal cellular suspension. Dermatol Surg. 2020, 46:1307-1314. 10.1097\/DSS.0000000000002329","journal-title":"Dermatol Surg"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S315407","article-title":"Transverse needling after autologous mini-punch grafts improves repigmentation in stable non-segmental vitiligo","volume":"14","author":"Ragab M","year":"2021","unstructured":"Ragab M, El Zagh O, Farid C. Transverse needling after autologous mini-punch grafts improves repigmentation in stable non-segmental vitiligo. Clin Cosmet Investig Dermatol. 2021, 14:827-835. 10.2147\/CCID.S315407","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14813","article-title":"A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo","volume":"34","author":"Neinaa YMEH","year":"2021","unstructured":"Neinaa YMEH, Lotfy SS, Ghaly NR, Doghaim NN. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo. Dermatol Ther. 2021, 34:e14813. 10.1111\/dth.14813","journal-title":"Dermatol Ther"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12072","article-title":"Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone","volume":"29","author":"Bansal S","year":"2013","unstructured":"Bansal S, Sahoo B, Garg V. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Photodermatol Photoimmunol Photomed. 2013, 29:311-317. 10.1111\/phpp.12072","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15596","article-title":"A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: a randomized, double-blind, placebo-controlled trial","volume":"35","author":"Charoenpongpun N","year":"2022","unstructured":"Charoenpongpun N, Kamanamool N, Udompataikul M, Khunkhet S, Kanokrungsee S. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: a randomized, double-blind, placebo-controlled trial. Dermatol Ther. 2022, 35:e15596. 10.1111\/dth.15596","journal-title":"Dermatol Ther"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/240856","article-title":"Narrow-band ultraviolet B versus oral minocycline in treatment of unstable vitiligo: a prospective comparative trial","volume":"2014","author":"Siadat AH","year":"2014","unstructured":"Siadat AH, Zeinali N, Iraji F, et al.. Narrow-band ultraviolet B versus oral minocycline in treatment of unstable vitiligo: a prospective comparative trial. Dermatol Res Pract. 2014, 2014:240856. 10.1155\/2014\/240856","journal-title":"Dermatol Res Pract"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12384","article-title":"The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial","volume":"29","author":"El Mofty M","year":"2016","unstructured":"El Mofty M, Essmat S, Youssef R, et al.. The role of systemic steroids and phototherapy in the treatment of stable vitiligo: a randomized controlled trial. Dermatol Ther. 2016, 29:406-412. 10.1111\/dth.12384","journal-title":"Dermatol Ther"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19347","article-title":"Combination of NB-UVB phototherapy and oral vitamin D supplementation in patients with generalized vitiligo: a randomized, triple-blind, placebo-controlled clinical trial","volume":"37","author":"Garza-Davila VF","year":"2023","unstructured":"Garza-Davila VF, Valdespino-Valdes J, Ramos A, et al.. Combination of NB-UVB phototherapy and oral vitamin D supplementation in patients with generalized vitiligo: a randomized, triple-blind, placebo-controlled clinical trial. J Eur Acad Dermatol Venereol. 2023, 37:e1423-e1425. 10.1111\/jdv.19347","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1595506","article-title":"Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone","volume":"31","author":"Jowkar F","year":"2020","unstructured":"Jowkar F, Godarzi H, Parvizi MM. Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone. J Dermatol Treat. 2020, 31:256-260. 10.1080\/09546634.2019.1595506","journal-title":"J Dermatol Treat"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.11.031","article-title":"Apremilast in combination with narrowband UVB in the treatment of vitiligo: a 52-week monocentric prospective randomized placebo-controlled study","volume":"140","author":"Khemis A","year":"2020","unstructured":"Khemis A, Fontas E, Moulin S, Montaudi\u00e9 H, Lacour JP, Passeron T. Apremilast in combination with narrowband UVB in the treatment of vitiligo: a 52-week monocentric prospective randomized placebo-controlled study. J Investig Dermatol. 2020, 140:1533-1537. 10.1016\/j.jid.2019.11.031","journal-title":"J Investig Dermatol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1875","article-title":"Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo a randomized multicenter trial","volume":"151","author":"Lim HW","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O, et al.. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo a randomized multicenter trial. JAMA Dermatol. 2015, 151:42-50. 10.1001\/jamadermatol.2014.1875","journal-title":"JAMA Dermatol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3777109","article-title":"Influence of oral supplementation of Vitamins A and E on the effectiveness of vitiligo treatment","volume":"2023","author":"Nowowiejska L","year":"2023","unstructured":"Nowowiejska L, Marek-J\u00f3zefowicz L, Szewczyk-Golec K, et al.. Influence of oral supplementation of Vitamins A and E on the effectiveness of vitiligo treatment. Dermatol Ther. 2023, 2023:3777109. 10.1155\/2023\/3777109","journal-title":"Dermatol Ther"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13184","article-title":"Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: a randomised clinical trial","volume":"61","author":"Zabolinejad N","year":"2020","unstructured":"Zabolinejad N, Maleki M, Salehi M, Ashrafi Z, Molkara S, Layegh P. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: a randomised clinical trial. Austral J Dermatol. 2020, 61:65-69. 10.1111\/ajd.13184","journal-title":"Austral J Dermatol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12749","article-title":"Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): a double-blind, randomized, placebo-controlled, prospective, multicenter study","volume":"38","author":"Esmat SM","year":"2022","unstructured":"Esmat SM, El-Mofty M, Rasheed H, et al.. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): a double-blind, randomized, placebo-controlled, prospective, multicenter study. Photodermatol Photoimmunol Photomed. 2022, 38:277-287. 10.1111\/phpp.12749","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17331","article-title":"Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: a 24-week prospective randomized placebo-controlled study","volume":"35","author":"Fontas E","year":"2021","unstructured":"Fontas E, Montaudi\u00e9 H, Passeron T. Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: a 24-week prospective randomized placebo-controlled study. J Eur Acad Dermatol Venereol. 2021, 35:1725-1729. 10.1111\/jdv.17331","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2015.1114646","article-title":"Triple-combination treatment with oral alpha-lipoic acid, betamethasone injection, and NB-UVB for non-segmental progressive vitiligo","volume":"18","author":"Li L","year":"2016","unstructured":"Li L, Wu Y, Gao XH, Chen HD. Triple-combination treatment with oral alpha-lipoic acid, betamethasone injection, and NB-UVB for non-segmental progressive vitiligo. J Cosmet Laser Ther. 2016, 18:182-185. 10.3109\/14764172.2015.1114646","journal-title":"J Cosmet Laser Ther"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20165354","article-title":"Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo","volume":"49","author":"Mou KH","year":"2016","unstructured":"Mou KH, Han D, Liu WL, Li P. Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo. Braz\u00a0J\u00a0Med\u00a0Biol\u00a0Res. 2016, 49:10.1590\/1414-431X20165354","journal-title":"Braz\u00a0J\u00a0Med\u00a0Biol\u00a0Res"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14776","article-title":"NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo","volume":"34","author":"Pacifico A","year":"2021","unstructured":"Pacifico A, Damiani G, Iacovelli P, Conic RRZ, Gonzalez S, Morrone A. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo. Dermatol Ther. 2021, 34:e14776. 10.1111\/dth.14776","journal-title":"Dermatol Ther"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4464\/MC.2013.41.5.5090","article-title":"Effects of oral Polypodium leucotomos extract as adjuvant in the treatment of vitiligo with narrow-band","volume":"41","author":"Salazar GZ","year":"2013","unstructured":"Salazar GZ, Cedeno M, Roman VP, Pazmino RU. Effects of oral Polypodium leucotomos extract as adjuvant in the treatment of vitiligo with narrow-band. UVB. 2013, 41:205-209. 10.4464\/MC.2013.41.5.5090","journal-title":"UVB"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14610","article-title":"Randomized clinical trial of combined therapy with oral \u03b1-lipoic acid and NB-UVB for nonsegmental stable vitiligo","volume":"34","author":"Sun Y","year":"2021","unstructured":"Sun Y, Guan X, Wang H, et al.. Randomized clinical trial of combined therapy with oral \u03b1-lipoic acid and NB-UVB for nonsegmental stable vitiligo. Dermatol Ther. 2021, 34:e14610. 10.1111\/dth.14610","journal-title":"Dermatol Ther"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.6401","article-title":"Atorvastatin in combination with narrowband UV-B in adult patients with active vitiligo: a randomized clinical trial","volume":"154","author":"Nguyen S","year":"2018","unstructured":"Nguyen S, Chuah SY, Fontas E, et al.. Atorvastatin in combination with narrowband UV-B in adult patients with active vitiligo: a randomized clinical trial. JAMA Dermatol. 2018, 154:725-726. 10.1001\/jamadermatol.2017.6401","journal-title":"JAMA Dermatol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12808","article-title":"The role of long-wavelength ultraviolet A1 (UVA1) in acral vitiligo","volume":"18","author":"El-Zawahry BM","year":"2019","unstructured":"El-Zawahry BM, Elmasry MF, Ragab A. The role of long-wavelength ultraviolet A1 (UVA1) in acral vitiligo. J Cosmet Dermatol. 2019, 18:1155-1160. 10.1111\/jocd.12808","journal-title":"J Cosmet Dermatol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/472546","article-title":"Evaluation of the efficacy of topical tetracycline in enhancing the effect of narrow band UVB against vitiligo: a double-blind, randomized, placebo-controlled clinical trial","volume":"2014","author":"Kalafi A","year":"2014","unstructured":"Kalafi A, Jowkar F. Evaluation of the efficacy of topical tetracycline in enhancing the effect of narrow band UVB against vitiligo: a double-blind, randomized, placebo-controlled clinical trial. ISRN Dermatol. 2014, 2014:472546. 10.1155\/2014\/472546","journal-title":"ISRN Dermatol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14697","article-title":"A new, innovative, and safe treatment in vitiligo: Results of a randomized, double-blinded, parallel-group study","volume":"34","author":"Diehl C","year":"2021","unstructured":"Diehl C, Sadoughifar R, Binic I, Golubovic M. A new, innovative, and safe treatment in vitiligo: Results of a randomized, double-blinded, parallel-group study. Dermatol Ther. 2021, 34:e14697. 10.1111\/dth.14697","journal-title":"Dermatol Ther"},{"key":"ref98","article-title":"Evaluation of the efficacy of topical ethyl vanillate in enhancing the effect of narrow band ultraviolet b against vitiligo: a double blind randomized, placebo-controlled clinical trial","volume":"40","author":"Namazi MR","year":"2015","unstructured":"Namazi MR, Shotorbani AK. Evaluation of the efficacy of topical ethyl vanillate in enhancing the effect of narrow band ultraviolet b against vitiligo: a double blind randomized, placebo-controlled clinical trial. Iran J Med Sci. 2015, 40:478-484.","journal-title":"Iran J Med Sci"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32591-8","article-title":"The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study","volume":"13","author":"Silpa-Archa N","year":"2023","unstructured":"Silpa-Archa N, Likittanasombat S, Apinuntham C, et al.. The efficacy of bimatoprost ophthalmic solution combined with NB-UVB phototherapy in non-segmental and segmental vitiligo: a single-blind randomized controlled study. Sci Rep. 2023, 13:6438. 10.1038\/s41598-023-32591-8","journal-title":"Sci Rep"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.777381","article-title":"Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasoneand calcipotriol in vitiligo","volume":"25","author":"Akdeniz N","year":"2014","unstructured":"Akdeniz N, Yavuz IH, Bilgili SG, Yavuz GO, Calka O. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasoneand calcipotriol in vitiligo. J Dermatol Treat. 2014, 25:196-199. 10.3109\/09546634.2013.777381","journal-title":"J Dermatol Treat"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2252119","article-title":"Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol\/betamethasone in combination with NBUVB in treatment of vitiligo","volume":"34","author":"Alshiyab D","year":"2023","unstructured":"Alshiyab D, Al-qarqaz F, Ba-shammakh S, et al.. Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol\/betamethasone in combination with NBUVB in treatment of vitiligo. J Dermatol Treat. 2023, 34:10.1080\/09546634.2023.2252119","journal-title":"J Dermatol Treat"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12631","article-title":"The effect of latanoprost on vitiligo: a preliminary comparative study","volume":"54","author":"Anbar TS","year":"2015","unstructured":"Anbar TS, El-Ammawi TS, Abdel-Rahman AT, Hanna MR. The effect of latanoprost on vitiligo: a preliminary comparative study. Int J Dermatol. 2015, 54:587-593. 10.1111\/ijd.12631","journal-title":"Int J Dermatol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3310\/hta24640","article-title":"Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT","volume":"24","author":"Batchelor JM","year":"2020","unstructured":"Batchelor JM, Thomas KS, Akram P, et al.. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT. Health Technol Assess. 2020, 24:1-128. 10.3310\/hta24640","journal-title":"Health Technol Assess"},{"key":"ref104","article-title":"Efficacy of 0.1% topical tacrolimus with narrow band ultraviolet B phototherapy versus narrow band ultraviolet B phototherapy in vitiligo","volume":"24","author":"Bilal A","year":"2014","unstructured":"Bilal A, Shiakh ZI, Khan S, Iftikhar N, Anwar I, Sadiq S. Efficacy of 0.1% topical tacrolimus with narrow band ultraviolet B phototherapy versus narrow band ultraviolet B phototherapy in vitiligo. J Pak Assoc Dermatol. 2014, 24:327-331.","journal-title":"J Pak Assoc Dermatol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12726","article-title":"Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial","volume":"29","author":"Khullar G","year":"2015","unstructured":"Khullar G, Kanwar AJ, Singh S, Parsad D. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial. J Eur Acad Dermatol Venerol. 2015, 29:925-932. 10.1111\/jdv.12726","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.095","article-title":"Successful treatment of vitiligo Vietnamese patients with Vitilinex\u00ae herbal bio-actives in combination with phototherapy","volume":"7","author":"Nguyen Van T","year":"2019","unstructured":"Nguyen Van T, Trinh Minh T, Le Huu D, et al.. Successful treatment of vitiligo Vietnamese patients with Vitilinex\u00ae herbal bio-actives in combination with phototherapy. Viet Dermatol. 2019, 7:283-286. 10.3889\/oamjms.2019.095","journal-title":"Viet Dermatol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.12.028","article-title":"Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study","volume":"141","author":"Seneschal J","year":"2021","unstructured":"Seneschal J, Duplaine A, Maillard H, et al.. Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study. J Investig Dermatol. 2021, 141:1728-1734. 10.1016\/j.jid.2020.12.028","journal-title":"J Investig Dermatol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-019-00653-y","article-title":"Novel bergamot oil nanospanlastics combined with PUVB therapy as a clinically translatable approach for vitiligo treatment","volume":"9","author":"Shaaban M","year":"2019","unstructured":"Shaaban M, Nasr M, Tawfik AA, Fadel M, Sammour O. Novel bergamot oil nanospanlastics combined with PUVB therapy as a clinically translatable approach for vitiligo treatment. Drug Deliv Transl Res. 2019, 9:1106-1116. 10.1007\/s13346-019-00653-y","journal-title":"Drug Deliv Transl Res"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6116","article-title":"The effect of topical piperine combined with narrowband UVB on vitiligo treatment: a clinical trial study","volume":"32","author":"Shafiee A","year":"2018","unstructured":"Shafiee A, Hoormand M, Shahidi-Dadras M, Abadi A. The effect of topical piperine combined with narrowband UVB on vitiligo treatment: a clinical trial study. Phytother Res. 2018, 32:1812-1817. 10.1002\/ptr.6116","journal-title":"Phytother Res"},{"key":"ref110","article-title":"Efficacy of tacrolimus plus narrowband ultraviolet B phototherapy versus narrowband ultraviolet B phototherapy alone in the treatment of vitiligo","volume":"27","author":"Ullah G","year":"2017","unstructured":"Ullah G, Rehman S, Noor SM, Paracha MM. Efficacy of tacrolimus plus narrowband ultraviolet B phototherapy versus narrowband ultraviolet B phototherapy alone in the treatment of vitiligo. J Pak Assoc Dermatol. 2017, 27:232-237.","journal-title":"J Pak Assoc Dermatol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5795","article-title":"Combination of follicular and epidermal cell suspension as a novel surgical approach in difficult-to-treat vitiligo a randomized clinical trial","volume":"154","author":"Muhammed RT","year":"2018","unstructured":"Muhammed RT, Kumar R, Rani S, Kumaran SM, Tanwar S, Parsad D. Combination of follicular and epidermal cell suspension as a novel surgical approach in difficult-to-treat vitiligo a randomized clinical trial. JAMA Dermatol. 2018, 154:301-308. 10.1001\/jamadermatol.2017.5795","journal-title":"JAMA Dermatol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_1010_2021","article-title":"Comparative study of the efficacy and safety of two grafting procedures (an automated epidermal harvesting system and non-cultured epidermal cell suspension) in the treatment of stable vitiligo","volume":"89","author":"Oberoi B","year":"2023","unstructured":"Oberoi B, Baveja S, Pathania V, Neema S. Comparative study of the efficacy and safety of two grafting procedures (an automated epidermal harvesting system and non-cultured epidermal cell suspension) in the treatment of stable vitiligo. Indian J Dermatol Venereol Leprol. 2023, 89:536-542. 10.25259\/IJDVL_1010_2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14683","article-title":"A prospective, randomized clinical study to compare the efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller in autologous noncultured epidermal cell suspension in stable vitiligo.","volume":"34","author":"Subburaj K","year":"2021","unstructured":"Subburaj K, Thakur V, Kumaran MS, Vinay K, Srivastava N, Parsad D. A prospective, randomized clinical study to compare the efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller in autologous noncultured epidermal cell suspension in stable vitiligo. . Dermatol Ther. 2021, 34:e14683. 10.1111\/dth.14683","journal-title":"Dermatol Ther"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14061","article-title":"A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo","volume":"45","author":"Vashisht KR","year":"2020","unstructured":"Vashisht KR, Arava SK, Tembhre MK, et al.. A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo. Clin Exp Dermatol. 2020, 45:172-179. 10.1111\/ced.14061","journal-title":"Clin Exp Dermatol"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2013.09.004","article-title":"A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo","volume":"70","author":"Verma R","year":"2014","unstructured":"Verma R, Grewal RS, Chatterjee M, Pragasam V, Vasudevan B, Mitra D. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Med J Armed Forces India. 2014, 70:26-31. 10.1016\/j.mjafi.2013.09.004","journal-title":"Med J Armed Forces India"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_205_20","article-title":"Tertiary health care-based randomized controlled study to compare autologous, non-cultured, non-trypsinized epidermal cell transplant (Jodhpur technique) with split-thickness skin grafting (STSG) in stable vitiligo","volume":"15","author":"Verma M","year":"2022","unstructured":"Verma M, Saini S, Rao P, Chouhan C, Kachhawa D. Tertiary health care-based randomized controlled study to compare autologous, non-cultured, non-trypsinized epidermal cell transplant (Jodhpur technique) with split-thickness skin grafting (STSG) in stable vitiligo. J Cutan Aesthet Surg. 2022, 15:33-39. 10.4103\/JCAS.JCAS_205_20","journal-title":"J Cutan Aesthet Surg"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13193","article-title":"Microdermabrasion and topical tacrolimus: a novel combination therapy of vitiligo","volume":"19","author":"Abd-Elazim NE","year":"2020","unstructured":"Abd-Elazim NE, Yassa HA, Mahran AM. Microdermabrasion and topical tacrolimus: a novel combination therapy of vitiligo. J Cosmet Dermatol. 2020, 19:1447-1455. 10.1111\/jocd.13193","journal-title":"J Cosmet Dermatol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14750","article-title":"Effectiveness of dermabrasion plus 5-fluorouracil vs suction blister in treating vitiligo: a comparative study","volume":"34","author":"Asilian A","year":"2021","unstructured":"Asilian A, Kazemipour S, Mokhtari F, et al.. Effectiveness of dermabrasion plus 5-fluorouracil vs suction blister in treating vitiligo: a comparative study. Dermatol Ther. 2021, 34:14750. 10.1111\/dth.14750","journal-title":"Dermatol Ther"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.4103\/ejdv.ejdv_41_22","article-title":"Efficacy of combination therapy with microneedling and topical latanoprost 0.005% in treatment of acrofacial vitiligo: a randomized controlled trial","volume":"43","author":"El-Magid WMA","year":"2023","unstructured":"El-Magid WMA, Mohamed M, Abd-Elghany NI, Saleh R. Efficacy of combination therapy with microneedling and topical latanoprost 0.005% in treatment of acrofacial vitiligo: a randomized controlled trial. Egyptian J of Dermatol and Venerol. 2023, 43:112-121. 10.4103\/ejdv.ejdv_41_22","journal-title":"Egyptian J of Dermatol and Venerol"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13304","article-title":"Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment","volume":"19","author":"Ebrahim HM","year":"2020","unstructured":"Ebrahim HM, Albalate W. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment. J Cosmet Dermatol. 2020, 19:855-862. 10.1111\/jocd.13304","journal-title":"J Cosmet Dermatol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1716930","article-title":"Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment","volume":"32","author":"Ebrahim HM","year":"2021","unstructured":"Ebrahim HM, Elkot R, Albalate W. Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment. J Dermatol Treat. 2021, 32:999-1004. 10.1080\/09546634.2020.1716930","journal-title":"J Dermatol Treat"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14024","article-title":"Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: a comparative study","volume":"20","author":"Esmat SM","year":"2021","unstructured":"Esmat SM, Gawdat HI, Hegazy RA, Ahmed FS, Said ER. Different methods of enhancing the efficacy of topical tacrolimus in extra-facial vitiligo: a comparative study. J Cosmet Dermatol. 2021, 20:3545-3551. 10.1111\/jocd.14024","journal-title":"J Cosmet Dermatol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5652140","article-title":"Microneedling in combination with topical pimecrolimus 1% versus topical pimecrolimus 1% for the treatment of refractory stable vitiligo: a randomized clinical trial","volume":"2021","author":"Iraji F","year":"2021","unstructured":"Iraji F, Asilian A, Talebzadeh Z, et al.. Microneedling in combination with topical pimecrolimus 1% versus topical pimecrolimus 1% for the treatment of refractory stable vitiligo: a randomized clinical trial. Dermatol Res Pract. 2021, 2021:5652140. 10.1155\/2021\/5652140","journal-title":"Dermatol Res Pract"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.5114\/dr.2021.111306","article-title":"A single blind active controlled study to compare the efficacy of microneedling and microneedling with 5-flurouracil in treatment of stable vitiligo","volume":"108","author":"Jartarkar SR","year":"2021","unstructured":"Jartarkar SR, Manjunath KG, Harini S, Sampath S. A single blind active controlled study to compare the efficacy of microneedling and microneedling with 5-flurouracil in treatment of stable vitiligo. Przeglad Dermatol. 2021, 108:275-284. 10.5114\/dr.2021.111306","journal-title":"Przeglad Dermatol"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.31838\/jcdr.2022.13.08.392","article-title":"Comparative evaluation of microneedling followed by methotrexate 1% gel versus microneedling followed by tacrolimus solution (0.1%) in localised stable vitiligo","volume":"13","author":"Kumari P","year":"2022","unstructured":"Kumari P, Singh PK, Kakkar S, Alam M, Phad P, Kumar R. Comparative evaluation of microneedling followed by methotrexate 1% gel versus microneedling followed by tacrolimus solution (0.1%) in localised stable vitiligo. J Cardiovasc Dis Res. 2022, 13:3021-3024. 10.31838\/jcdr.2022.13.08.392","journal-title":"J Cardiovasc Dis Res"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15294","article-title":"Microneedling combined with pimecrolimus, 5-fluorouracil, and trichloroacetic acid in the treatment of vitiligo: a comparative study","volume":"35","author":"Nofal A","year":"2022","unstructured":"Nofal A, Eldeeb F, Shalaby M, Al-Balat W. Microneedling combined with pimecrolimus, 5-fluorouracil, and trichloroacetic acid in the treatment of vitiligo: a comparative study. Dermatol Ther. 2022, 35:e15294. 10.1111\/dth.15294","journal-title":"Dermatol Ther"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15616","article-title":"The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: a randomized controlled trial","volume":"22","author":"Pazyar N","year":"2023","unstructured":"Pazyar N, Hatami M, Yaghoobi R, Parvar SY, Radmanesh M, Hadibarhaghtalab M. The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: a randomized controlled trial. J Cosmet Dermatol. 2023, 22:1513-1520. 10.1111\/jocd.15616","journal-title":"J Cosmet Dermatol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_12_20","article-title":"Efficacy of topical 5% 5-fluorouracil with needling versus 5% 5-fluorouracil alone in stable vitiligo: a randomized controlled study","volume":"13","author":"Zahra FT","year":"2020","unstructured":"Zahra FT, Adil M, Amin SS, Mohtashim M, Bansal R, Khan HQ. Efficacy of topical 5% 5-fluorouracil with needling versus 5% 5-fluorouracil alone in stable vitiligo: a randomized controlled study. J Cut Aesthet Surg. 2020, 13:197-203. 10.4103\/JCAS.JCAS_12_20","journal-title":"J Cut Aesthet Surg"},{"key":"ref129","article-title":"Evaluation of a standardized extract of Ginkgo biloba in vitiligo remedy","volume":"6","author":"Abu-Raghif AR","year":"2013","unstructured":"Abu-Raghif AR, Ali NM, Farhood IG, Hameed MF, Sahib HB. Evaluation of a standardized extract of Ginkgo biloba in vitiligo remedy. Asian J Pharm Clin Res. 2013, 6:127-130.","journal-title":"Asian J Pharm Clin Res"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15033","article-title":"Oral cyclosporine is effective in stabilizing active vitiligo: Results of a randomized controlled trial","volume":"34","author":"Mehta H","year":"2021","unstructured":"Mehta H, Kumar S, Parsad D, Bishnoi A, Vinay K, Kumaran MS. Oral cyclosporine is effective in stabilizing active vitiligo: Results of a randomized controlled trial. Dermatol Ther. 2021, 34:e15033. 10.1111\/dth.15033","journal-title":"Dermatol Ther"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.125479","article-title":"Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris","volume":"80","author":"Singh A","year":"2014","unstructured":"Singh A, Kanwar A, Parsad D, Mahajan R. Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. Indian J Dermatol Venereol Leprol. 2014, 80:29-35. 10.4103\/0378-6323.125479","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1159\/000433424","article-title":"A randomized comparative study of oral corticosteroid minipulse and low-dose oral methotrexate in the treatment of unstable vitiligo","volume":"231","author":"Singh H","year":"2015","unstructured":"Singh H, Kumaran MS, Bains A, Parsad D. A randomized comparative study of oral corticosteroid minipulse and low-dose oral methotrexate in the treatment of unstable vitiligo. Dermatol. 2015, 231:286-290. 10.1159\/000433424","journal-title":"Dermatol"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.06.015","article-title":"A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo","volume":"76","author":"Vanderweil SG","year":"2017","unstructured":"Vanderweil SG, Amano S, Ko WC, et al.. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Am Acad Dermatol. 2017, 76:150-151. 10.1016\/j.jaad.2016.06.015","journal-title":"J Am Acad Dermatol"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02108-8","article-title":"Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study","volume":"313","author":"Bishnoi A","year":"2021","unstructured":"Bishnoi A, Vinay K, Kumaran MS, Parsad D. Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study. Arch Dermatol. 2021, 313:357-365. 10.1007\/s00403-020-02108-8","journal-title":"Arch Dermatol"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13586","article-title":"Combination of oral methotrexate and oral mini-pulse dexamethasone vs either agent alone in vitiligo treatment with follow up by dermoscope","volume":"33","author":"ElGhareeb MI","year":"2020","unstructured":"ElGhareeb MI, Metwalli M, AbdelMoneim N. Combination of oral methotrexate and oral mini-pulse dexamethasone vs either agent alone in vitiligo treatment with follow up by dermoscope. Dermatol Ther. 2020, 33:e13586. 10.1111\/dth.13586","journal-title":"Dermatol Ther"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.11.005","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial","volume":"88","author":"Ezzedine K","year":"2023","unstructured":"Ezzedine K, Peeva E, Yamaguchi Y, et al.. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial. J Am Acad Dermatol. 2023, 88:395-403. 10.1016\/j.jaad.2022.11.005","journal-title":"J Am Acad Dermatol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.025","article-title":"A randomized comparative study of the effect of betamethasone oral mini-pulse therapy versus oral azathioprine in progressive nonsegmental vitiligo","volume":"85","author":"Patra S","year":"2021","unstructured":"Patra S, Khaitan BK, Sharma VK, Khanna N. A randomized comparative study of the effect of betamethasone oral mini-pulse therapy versus oral azathioprine in progressive nonsegmental vitiligo. J Am Acad Dermatol. 2021, 85:728-729. 10.1016\/j.jaad.2019.03.025","journal-title":"J Am Acad Dermatol"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14814","article-title":"Therapeutic effects of turmeric topical cream in vitiligo: a randomized, double-blind, placebo-controlled pilot study","volume":"21","author":"Jalalmanesh S","year":"2022","unstructured":"Jalalmanesh S, Mansouri P, Rajabi M, Monji F. Therapeutic effects of turmeric topical cream in vitiligo: a randomized, double-blind, placebo-controlled pilot study. J Cosmet Dermatol. 2022, 21:4454-4461. 10.1111\/jocd.14814","journal-title":"J Cosmet Dermatol"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin D","year":"2020","unstructured":"Rosmarin D, Pandya AG, Lebwohl M, et al.. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Lancet. 2020, 396:110-120. 10.1016\/S0140-6736(20)30609-7","journal-title":"Lancet"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin D","year":"2022","unstructured":"Rosmarin D, Passeron T, Pandya AG, et al.. Two phase 3, randomized, controlled trials of Ruxolitinib cream for vitiligo. N\u00a0Engl\u00a0J\u00a0Med. 2022, 387:1445-1455. 10.1056\/NEJMoa2118828","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14041","article-title":"Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental vitiligo: a randomized, controlled trial","volume":"20","author":"Saleh R","year":"2021","unstructured":"Saleh R, Ahmed AAE, M Abd-Elmagid W. Efficacy of topical tacrolimus 0.03% monotherapy in the treatment of non-segmental vitiligo: a randomized, controlled trial. J Cosmet Dermatol. 2021, 20:3943-3952. 10.1111\/jocd.14041","journal-title":"J Cosmet Dermatol"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.4103\/ijpd.IJPD_110_19","article-title":"A comparative study in treatment of childhood vitiligo 0.03% tacrolimus versus 0.03% tacrolimus and topical steroids","volume":"22","author":"Venkatesan A","year":"2021","unstructured":"Venkatesan A, Sriram R, Balaji S, Anandhi TK. A comparative study in treatment of childhood vitiligo 0.03% tacrolimus versus 0.03% tacrolimus and topical steroids. Indian J Paediatric Dermatol. 2021, 22:123-130. 10.4103\/ijpd.IJPD_110_19","journal-title":"Indian J Paediatric Dermatol"},{"key":"ref143","article-title":"Comparison of efficacy and safety of 0.005% calcipotriol ointment versus 0.05% betamethasone dipropionate ointment versus calcipotriol plus betamethasone ointment for the treatment of vitiligo","volume":"27","author":"Zahoor M","year":"2017","unstructured":"Zahoor M, Shaukat S, Khan MS, Ahmad TJ. Comparison of efficacy and safety of 0.005% calcipotriol ointment versus 0.05% betamethasone dipropionate ointment versus calcipotriol plus betamethasone ointment for the treatment of vitiligo. J Pak Assoc Dermatol. 2017, 27:30-36.","journal-title":"J Pak Assoc Dermatol"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.04.019","article-title":"Successful treatment of vitiligo with cold atmospheric plasma-activated hydrogel","volume":"141","author":"Zhai SY","year":"2020","unstructured":"Zhai SY, Xu MF, Li QS, et al.. Successful treatment of vitiligo with cold atmospheric plasma-activated hydrogel. J Invest Dermatol. 2020, 141:2710. 10.1016\/j.jid.2021.04.019","journal-title":"J Invest Dermatol"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1729952","article-title":"Comparison of the efficacy of tacrolimus 0.1% ointment and tacrolimus 0.1% plus topical pseudocatalase\/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial","volume":"33","author":"Alshiyab DM","year":"2022","unstructured":"Alshiyab DM, Al-qarqaz FA, Muhaidat JM, Alkhader YS, Al-sheyab RF, Jafaar SI. Comparison of the efficacy of tacrolimus 0.1% ointment and tacrolimus 0.1% plus topical pseudocatalase\/superoxide dismutase gel in children with limited vitiligo: a randomized controlled trial. J Dermatol Treat. 2022, 33:146-149. 10.1080\/09546634.2020.1729952","journal-title":"J Dermatol Treat"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12115","article-title":"Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation","volume":"27","author":"Goren A","year":"2014","unstructured":"Goren A, Salafia A, McCoy J, Keene S, Lotti T. Novel topical cream delivers safe and effective sunlight therapy for vitiligo by selectively filtering damaging ultraviolet radiation. Dermatol Ther. 2014, 27:195-197. 10.1111\/dth.12115","journal-title":"Dermatol Ther"},{"key":"ref147","article-title":"Bimatoprost 0.03% solution for the treatment of nonfacial vitiligo","volume":"15","author":"Grimes PE","year":"2016","unstructured":"Grimes PE. Bimatoprost 0.03% solution for the treatment of nonfacial vitiligo. J Drugs Dermatol. 2016, 15:703-710.","journal-title":"J Drugs Dermatol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1177\/2156587215577675","article-title":"A randomized double blind clinical trial on a Sabgh formulation for patients with vitiligo","volume":"20","author":"Hosseinkhani A","year":"2015","unstructured":"Hosseinkhani A, Montaseri H, Sodaifi M, Mohagheghzadeh A, Seradj H, Afshari-Jouybari H. A randomized double blind clinical trial on a Sabgh formulation for patients with vitiligo. J Evid Based Complement Alternat Med. 2015, 20:254-258. 10.1177\/2156587215577675","journal-title":"J Evid Based Complement Alternat Med"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13648","article-title":"Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: a preliminary study","volume":"20","author":"Kanokrungsee S","year":"2021","unstructured":"Kanokrungsee S, Pruettivorawongse D, Rajatanavin N. Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: a preliminary study. J Cosmet Dermatol. 2021, 20:812-818. 10.1111\/jocd.13648","journal-title":"J Cosmet Dermatol"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19362","article-title":"A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo","volume":"37","author":"Kumar D","year":"2023","unstructured":"Kumar D, Thakur V, Subburaj K, et al.. A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo. J Eur Acad Dermatol Venereol. 2023, 37:2243-2248. 10.1111\/jdv.19362","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13175","article-title":"Efficacy of topical latanoprost in the treatment of eyelid vitiligo: a randomized, double-blind clinical trial study","volume":"33","author":"Nowroozpoor Dailami K","year":"2020","unstructured":"Nowroozpoor Dailami K, Hosseini A, Rahmatpour Rokni G, et al.. Efficacy of topical latanoprost in the treatment of eyelid vitiligo: a randomized, double-blind clinical trial study. Dermatol Ther. 2020, 33:e13175. 10.1111\/dth.13175","journal-title":"Dermatol Ther"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.02.005","article-title":"Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo \u2014 part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies","volume":"119","author":"Patel HK","year":"2014","unstructured":"Patel HK, Barot BS, Parejiya PB, Shelat PK, Shukla A. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo \u2014 part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies. Colloids Surf B: Biointerfaces. 2014, 119:145-153. 10.1016\/j.colsurfb.2014.02.005","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13109","article-title":"Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo","volume":"32","author":"Shah B","year":"2019","unstructured":"Shah B, Godse K, Mahajan S, et al.. Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. Dermatol Ther. 2019, 32:e13109. 10.1111\/dth.13109","journal-title":"Dermatol Ther"},{"key":"ref154","article-title":"An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area","volume":"16","author":"Shrestha S","year":"2014","unstructured":"Shrestha S, Jha AK, Thapa DP, Bhattarai CK, Ghimire A. An open label study to compare the efficacy of topical mometasone furoate with topical placental extract versus topical mometasone furoate with topical tacrolimus in patients with vitiligo involving less than 10% body surface area. Nepal Med Coll J. 2014, 16:1-4.","journal-title":"Nepal Med Coll J"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsi.2016.05.005","article-title":"Comparison of the efficacy and safety of 0.1% tacrolimus ointment and 0.1% mometasone furoate cream for adult vitiligo: a single-blinded pilot study","volume":"34","author":"Silpa-Archa N","year":"2016","unstructured":"Silpa-Archa N, Nitayavardhana S, Thanomkitti K, Chularojanamontri L, Varothai S, Wongpraparut C. Comparison of the efficacy and safety of 0.1% tacrolimus ointment and 0.1% mometasone furoate cream for adult vitiligo: a single-blinded pilot study. Dermatol Sin. 2016, 34:177-179. 10.1016\/j.dsi.2016.05.005","journal-title":"Dermatol Sin"},{"key":"ref156","article-title":"To assess the efficacy of topical 0.03% tacrolimus ointment in the treatment of vitiligo","volume":"11","author":"Zaib","year":"2017","unstructured":"Zaib, Rashid S. To assess the efficacy of topical 0.03% tacrolimus ointment in the treatment of vitiligo. Pak J Med Health Sci. 2017, 11:616-619.","journal-title":"Pak J Med Health Sci"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study","volume":"135","author":"Cavali\u00e9 M","year":"2015","unstructured":"Cavali\u00e9 M, Ezzedine K, Fontas E, et al.. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol. 2015, 135:970-974. 10.1038\/jid.2014.527","journal-title":"J Invest Dermatol"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness LA","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021, 12:55-61. 10.1002\/jrsm.1411","journal-title":"Res Synth Methods"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.0002","article-title":"Phototherapy for vitiligo: a systematic review and meta-analysis","volume":"153","author":"Bae JM","year":"2017","unstructured":"Bae JM, Jung HM, Hong BY, et al.. Phototherapy for vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2017, 153:666-674. 10.1001\/jamadermatol.2017.0002","journal-title":"JAMA Dermatol"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2302064","article-title":"Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis","volume":"35","author":"Li C","year":"2024","unstructured":"Li C, Hu Y, Mu Z, et al.. Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis. J Dermatol Treat. 2024, 35:2302064. 10.1080\/09546634.2024.2302064","journal-title":"J Dermatol Treat"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-018-2516-7","article-title":"Fractional CO(2) laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis","volume":"33","author":"Chiu YJ","year":"2018","unstructured":"Chiu YJ, Perng CK, Ma H. Fractional CO(2) laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis. Lasers Med Sci. 2018, 33:1549-1556. 10.1007\/s10103-018-2516-7","journal-title":"Lasers Med Sci"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.07.053","article-title":"Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review","volume":"60","author":"Nicolaidou E","year":"2009","unstructured":"Nicolaidou E, Antoniou C, Stratigos A, Katsambas AD. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol. 2009, 60:470-477. 10.1016\/j.jaad.2008.07.053","journal-title":"J Am Acad Dermatol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000172","article-title":"Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial","volume":"40","author":"Esmat SM","year":"2014","unstructured":"Esmat SM, Elramly AZ, Halim DMA, Gawdat HI, Taha HI. Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial. Dermatol Surg. 2014, 40:1349-1355. 10.1097\/DSS.0000000000000172","journal-title":"Dermatol Surg"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.5978\/islsm.14-RE-01","article-title":"The role of the CO2 laser and fractional CO2 laser in dermatology","volume":"23","author":"Omi T","year":"2014","unstructured":"Omi T, Numano K. The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther. 2014, 23:49-60. 10.5978\/islsm.14-RE-01","journal-title":"Laser Ther"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18005","article-title":"The use of lasers in vitiligo, an overview","volume":"36","author":"Post NF","year":"2022","unstructured":"Post NF, Ezekwe N, Narayan VS, et al.. The use of lasers in vitiligo, an overview. J Eur Acad Dermatol Venereol. 2022, 36:779-789. 10.1111\/jdv.18005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref166","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2012.02354.x","article-title":"Autologous cultured melanocytes in vitiligo treatment comparison of two techniques to prepare the recipient site: erbium-doped yttrium aluminum garnet laser versus dermabrasion","volume":"38","author":"Fioramonti P","year":"2012","unstructured":"Fioramonti P, Onesti MG, Marchese C, Carella S, Ceccarelli S, Scuderi N. Autologous cultured melanocytes in vitiligo treatment comparison of two techniques to prepare the recipient site: erbium-doped yttrium aluminum garnet laser versus dermabrasion. Dermatol Surg. 2012, 38:809-812. 10.1111\/j.1524-4725.2012.02354.x","journal-title":"Dermatol Surg"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1080\/000155598433485","article-title":"Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo","volume":"78","author":"Kaufmann R","year":"1998","unstructured":"Kaufmann R, Greiner D, Kippenberger S, Bernd A. Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo. Acta Derm Venereol. 1998, 78:136-138. 10.1080\/000155598433485","journal-title":"Acta Derm Venereol"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2175","article-title":"The efficacy of a gain-switched 311-nm titanium:sapphire laser in the treatment of vitiligo: a pilot study of 14 patients","volume":"153","author":"Bae JM","year":"2017","unstructured":"Bae JM, Lee JH, Jung YS, Kim GM. The efficacy of a gain-switched 311-nm titanium:sapphire laser in the treatment of vitiligo: a pilot study of 14 patients. JAMA Dermatol. 2017, 153:1055-1056. 10.1001\/jamadermatol.2017.2175","journal-title":"JAMA Dermatol"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00951","article-title":"Ultraviolet radiation and melanomagenesis: from mechanism to immunotherapy","volume":"10","author":"Sun X","year":"2020","unstructured":"Sun X, Zhang N, Yin C, Zhu B, Li X. Ultraviolet radiation and melanomagenesis: from mechanism to immunotherapy. Front Oncol. 2020, 10:951. 10.3389\/fonc.2020.00951","journal-title":"Front Oncol"},{"key":"ref170","doi-asserted-by":"publisher","DOI":"10.1039\/c2pp25323b","article-title":"UVA1 is skin deep: molecular and clinical implications","volume":"12","author":"Tewari A","year":"2013","unstructured":"Tewari A, Grage MM, Harrison GI, Sarkany R, Young AR. UVA1 is skin deep: molecular and clinical implications. Photochem Photobiol Sci. 2013, 12:95-103. 10.1039\/c2pp25323b","journal-title":"Photochem Photobiol Sci"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197412052912301","article-title":"Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light","volume":"291","author":"Parrish JA","year":"1974","unstructured":"Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med\r\n. 1974, 291:1207-1211. 10.1056\/NEJM197412052912301","journal-title":"N Engl J Med"},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00845.x","article-title":"How are proliferation and differentiation of melanocytes regulated?","volume":"24","author":"Hirobe T","year":"2011","unstructured":"Hirobe T. How are proliferation and differentiation of melanocytes regulated?. Pigment Cell Melanoma Res. 2011, 24:462-478. 10.1111\/j.1755-148X.2011.00845.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2005.08.053","article-title":"How cold light was introduced to arthroscopy","volume":"22","author":"Kieser CW","year":"2006","unstructured":"Kieser CW, Jackson RW. How cold light was introduced to arthroscopy. Arthrosc J Arthrosc Relat Surg. 2006, 22:345-350. 10.1016\/j.arthro.2005.08.053","journal-title":"Arthrosc J Arthrosc Relat Surg"},{"key":"ref174","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.042","article-title":"Micro - focused phototherapy associated to Janus kinase inhibitor: a promising valid therapeutic option for patients with localized vitiligo","volume":"6","author":"Gianfaldoni S","year":"2018","unstructured":"Gianfaldoni S, Tchernev G, Wollina U, et al.. Micro - focused phototherapy associated to Janus kinase inhibitor: a promising valid therapeutic option for patients with localized vitiligo. Open Access Maced J Med Sci. 2018, 6:46-48. 10.3889\/oamjms.2018.042","journal-title":"Open Access Maced J Med Sci"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.09.006","article-title":"History of dermatology: the study of skin diseases over the centuries","volume":"96","author":"Ferreira IG","year":"2021","unstructured":"Ferreira IG, Weber MB, Bonamigo RR. History of dermatology: the study of skin diseases over the centuries. An Bras Dermatol. 2021, 96:332-345. 10.1016\/j.abd.2020.09.006","journal-title":"An Bras Dermatol"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.5756","article-title":"Surgical interventions for patients with vitiligo: a systematic review and meta-analysis","volume":"157","author":"Ju HJ","year":"2021","unstructured":"Ju HJ, Bae JM, Lee RW, et al.. Surgical interventions for patients with vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2021, 157:307-316. 10.1001\/jamadermatol.2020.5756","journal-title":"JAMA Dermatol"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.185468","article-title":"Microneedling: advances and widening horizons","volume":"7","author":"Singh A","year":"2016","unstructured":"Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016, 7:244-254. 10.4103\/2229-5178.185468","journal-title":"Indian Dermatol Online J"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14154","article-title":"Vitiligo effectively treated with electrocautery needling technique","volume":"33","author":"Yang L","year":"2020","unstructured":"Yang L, Wong PM, Yang L, Katayama I, Wu H, Zhang H. Vitiligo effectively treated with electrocautery needling technique. Dermatol Ther. 2020, 33:14154. 10.1111\/dth.14154","journal-title":"Dermatol Ther"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003503","article-title":"Utilization of our toolkit: a systematic review and meta-analysis of surgical therapies in vitiligo treatment","volume":"48","author":"McCrary MR","year":"2022","unstructured":"McCrary MR, Gibbs DC, Alharthi M, Krueger LD. Utilization of our toolkit: a systematic review and meta-analysis of surgical therapies in vitiligo treatment. Dermatol Surg. 2022, 48:815-821. 10.1097\/DSS.0000000000003503","journal-title":"Dermatol Surg"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.01889.x","article-title":"Satellite repigmentation after punch grafting","volume":"43","author":"Agarwal US","year":"2004","unstructured":"Agarwal US, Gulati R, Shukla SR, Mathur N. Satellite repigmentation after punch grafting. Int J Dermatol. 2004, 43:273-274. 10.1111\/j.1365-4632.2004.01889.x","journal-title":"Int J Dermatol"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.4103\/JCAS.JCAS_111_15","article-title":"Suction blister epidermal grafting for vitiligo involving angles of lip: experience of 112 patients","volume":"11","author":"Kar BR","year":"2018","unstructured":"Kar BR, Raj C. Suction blister epidermal grafting for vitiligo involving angles of lip: experience of 112 patients. J Cutan Aesthet Surg. 2018, 11:13-19. 10.4103\/JCAS.JCAS_111_15","journal-title":"J Cutan Aesthet Surg"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.26574\/maedica.2023.18.4.576","article-title":"A study of autologous non-cultured epidermal suspension (NCES) transplant in patients with stable vitiligo without the use of NB-UVB","volume":"18","author":"Chandela M","year":"2023","unstructured":"Chandela M, Khurana VK, Mehta RK, Saxena AK, Mohanty S, Jethani S. A study of autologous non-cultured epidermal suspension (NCES) transplant in patients with stable vitiligo without the use of NB-UVB. Maedica (Bucur. 2023, 18:576-585. 10.26574\/maedica.2023.18.4.576","journal-title":"Maedica (Bucur"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05960-6","article-title":"Dedifferentiation maintains melanocyte stem cells in a dynamic niche","volume":"616","author":"Sun Q","year":"2023","unstructured":"Sun Q, Lee W, Hu H, et al.. Dedifferentiation maintains melanocyte stem cells in a dynamic niche. Nature. 2023, 616:774-782. 10.1038\/s41586-023-05960-6","journal-title":"Nature"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(98)70121-5","article-title":"Single hair grafting for the treatment of vitiligo","volume":"38","author":"Na GY","year":"1998","unstructured":"Na GY, Seo SK, Choi SK. Single hair grafting for the treatment of vitiligo. J Am Acad Dermatol. 1998, 38:580-584. 10.1016\/s0190-9622(98)70121-5","journal-title":"J Am Acad Dermatol"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S239912","article-title":"The usefulness of platelet-rich plasma (PRP) for the treatment of vitiligo: state of the art and review","volume":"14","author":"Mercuri SR","year":"2020","unstructured":"Mercuri SR, Vollono L, Paolino G. The usefulness of platelet-rich plasma (PRP) for the treatment of vitiligo: state of the art and review. Drug Des Devel Ther. 2020, 14:1749-1755. 10.2147\/DDDT.S239912","journal-title":"Drug Des Devel Ther"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1983.01650330014006","article-title":"Topically administered fluorouracil in vitiligo","volume":"119","author":"Tsuji T","year":"1983","unstructured":"Tsuji T, Hamada T. Topically administered fluorouracil in vitiligo. Arch Dermatol. 1983, 119:722-727. 10.1001\/archderm.1983.01650330014006","journal-title":"Arch Dermatol"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha JS","year":"1993","unstructured":"Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol. 1993, 32:753-757. 10.1111\/j.1365-4362.1993.tb02754.x","journal-title":"Int J Dermatol"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15464","article-title":"Oral mini-pulse therapy in vitiligo: a systematic review","volume":"60","author":"Chavez-Alvarez S","year":"2021","unstructured":"Chavez-Alvarez S, Herz-Ruelas M, Raygoza-Cortez AK, et al.. Oral mini-pulse therapy in vitiligo: a systematic review. Int J Dermatol. 2021, 60:868-876. 10.1111\/ijd.15464","journal-title":"Int J Dermatol"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02343-1","article-title":"Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI","volume":"315","author":"Kim HJ","year":"2023","unstructured":"Kim HJ, Del Duca E, Pavel AB, et al.. Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI. Arch Dermatol Res. 2023, 315:215-221. 10.1007\/s00403-022-02343-1","journal-title":"Arch Dermatol Res"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu S","year":"2002","unstructured":"Zhu S, Stavrovskaya IG, Drozda M, et al.. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 2002, 417:74-78. 10.1038\/417074a","journal-title":"Nature"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1097\/01.lab.0000069521.42488.1b","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wankowicz-Kalinska A","year":"2003","unstructured":"Wankowicz-Kalinska A, van den Wijngaard RM, Tigges BJ, et al.. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest. 2003, 83:683-695. 10.1097\/01.lab.0000069521.42488.1b","journal-title":"Lab Invest"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: a review","volume":"12","author":"Qi F","year":"2021","unstructured":"Qi F, Liu F, Gao L. Janus kinase inhibitors in the treatment of vitiligo: a review. Front Immunol. 2021, 12:790125. 10.3389\/fimmu.2021.790125","journal-title":"Front Immunol"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112811","article-title":"A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes","volume":"14","author":"Speeckaert R","year":"2023","unstructured":"Speeckaert R, Belpaire A, Speeckaert MM, van Geel N. A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes. Front Immunol. 2023, 14:1112811. 10.3389\/fimmu.2023.1112811","journal-title":"Front Immunol"},{"key":"ref194","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvac047","article-title":"Immunomodulatory effect of different statin regimens on regulatory T-cells in patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials","volume":"9","author":"Greca E","year":"2023","unstructured":"Greca E, Kacimi O, Poudel S, et al.. Immunomodulatory effect of different statin regimens on regulatory T-cells in patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Pharmacother. 2023, 9:122-128. 10.1093\/ehjcvp\/pvac047","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.4.311","article-title":"Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4","volume":"59","author":"Rudwaleit M","year":"2000","unstructured":"Rudwaleit M, Yin Z, Siegert S, et al.. Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor alpha, increase of interleukin 10, and predicted by the initial concentration of interleukin 4. Ann Rheum Dis. 2000, 59:311-314. 10.1136\/ard.59.4.311","journal-title":"Ann Rheum Dis"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16114","article-title":"Systemic therapies in vitiligo: a review","volume":"62","author":"Fatima S","year":"2023","unstructured":"Fatima S, Abbas T, Refat MA, et al.. Systemic therapies in vitiligo: a review. Int J Dermatol. 2023, 62:279-289. 10.1111\/ijd.16114","journal-title":"Int J Dermatol"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15023","article-title":"The multi-target mechanism of Cyclosporin A in the treatment of vitiligo based on network pharmacology","volume":"34","author":"Lu H","year":"2021","unstructured":"Lu H, Xu J, Xie B, et al.. The multi-target mechanism of Cyclosporin A in the treatment of vitiligo based on network pharmacology. Dermatol Ther. 2021, 34:15023. 10.1111\/dth.15023","journal-title":"Dermatol Ther"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2009.00407.x","article-title":"Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity","volume":"11","author":"Ritter ML","year":"2009","unstructured":"Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Infect Dis. 2009, 11:290-297. 10.1111\/j.1399-3062.2009.00407.x","journal-title":"Transpl Infect Dis"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.5.2374","article-title":"Mycophenolate mofetil impairs the maturation and function of murine dendritic cells","volume":"165","author":"Mehling A","year":"2000","unstructured":"Mehling A, Grabbe S, Voskort M, Schwarz T, Luger TA, Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol. 2000, 165:2374-2381. 10.4049\/jimmunol.165.5.2374","journal-title":"J Immunol"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.2009.00595.x","article-title":"Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone","volume":"85","author":"Harms JH","year":"2009","unstructured":"Harms JH, Lautenschlager S, Minder CE, Minder EI. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone. Photochem Photobiol. 2009, 85:1434-1439. 10.1111\/j.1751-1097.2009.00595.x","journal-title":"Photochem Photobiol"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306426","article-title":"In vivo vitamin D target genes interconnect key signaling pathways of innate immunity","volume":"19","author":"Jaroslawska J","year":"2024","unstructured":"Jaroslawska J, Dastidar RG, Carlberg C. In vivo vitamin D target genes interconnect key signaling pathways of innate immunity. PLoS One. 2024, 19:0306426. 10.1371\/journal.pone.0306426","journal-title":"PLoS One"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.10.002","article-title":"Decreased circulatory levels of vitamin D in vitiligo: a meta-analysis","volume":"96","author":"Varikasuvu SR","year":"2021","unstructured":"Varikasuvu SR, Aloori S, Varshney S, Bhongir AV. Decreased circulatory levels of vitamin D in vitiligo: a meta-analysis. An Bras Dermatol. 2021, 96:284-294. 10.1016\/j.abd.2020.10.002","journal-title":"An Bras Dermatol"},{"key":"ref203","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.090351","article-title":"Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice","volume":"175","author":"Zattra E","year":"2009","unstructured":"Zattra E, Coleman C, Arad S, et al.. Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice. Am J Pathol. 2009, 175:1952-1961. 10.2353\/ajpath.2009.090351","journal-title":"Am J Pathol"},{"key":"ref204","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.05.045","article-title":"Decrease of ultraviolet A light-induced \"common deletion\" in healthy volunteers after oral Polypodium leucotomos extract supplement in a randomized clinical trial","volume":"62","author":"Villa A","year":"2010","unstructured":"Villa A, Viera MH, Amini S, et al.. Decrease of ultraviolet A light-induced \"common deletion\" in healthy volunteers after oral Polypodium leucotomos extract supplement in a randomized clinical trial. J Am Acad Dermatol. 2010, 62:511-513. 10.1016\/j.jaad.2009.05.045","journal-title":"J Am Acad Dermatol"},{"key":"ref205","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2007.00603.x","article-title":"A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TNF-alpha and iNOS expression, transcriptional activation and apoptosis","volume":"16","author":"Janczyk A","year":"2007","unstructured":"Janczyk A, Garcia-Lopez MA, Fernandez-Penas P, et al.. A Polypodium leucotomos extract inhibits solar-simulated radiation-induced TNF-alpha and iNOS expression, transcriptional activation and apoptosis. Exp Dermatol. 2007, 16:823-829. 10.1111\/j.1600-0625.2007.00603.x","journal-title":"Exp Dermatol"},{"key":"ref206","article-title":"Hepatoprotective and immunological effects of antioxidant drugs","volume":"15","author":"Lang I","year":"1990","unstructured":"Lang I, Nekam K, Gonzalez-Cabello R, Muzes G, Gergely P, Feher J. Hepatoprotective and immunological effects of antioxidant drugs. Tokai J Exp Clin Med. 1990, 15:123-127.","journal-title":"Tokai J Exp Clin Med"},{"key":"ref207","doi-asserted-by":"publisher","DOI":"10.1177\/2156587215571116","article-title":"Silybum marianum: beyond hepatoprotection","volume":"20","author":"Bahmani M","year":"2015","unstructured":"Bahmani M, Shirzad H, Rafieian S, Rafieian-Kopaei M. Silybum marianum: beyond hepatoprotection. J Evid Based Complementary Altern Med. 2015, 20:292-301. 10.1177\/2156587215571116","journal-title":"J Evid Based Complementary Altern Med"},{"key":"ref208","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.03.019","article-title":"Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase\/Akt- dependent mechanism","volume":"86","author":"Bitar MS","year":"2010","unstructured":"Bitar MS, Ayed AK, Abdel-Halim SM, Isenovic ER, Al-Mulla F. Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase\/Akt- dependent mechanism. Life Sci. 2010, 86:844-853. 10.1016\/j.lfs.2010.03.019","journal-title":"Life Sci"},{"key":"ref209","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12655","article-title":"Regulation of Th1\/Th2 balance through OX40\/OX40L signalling by glycyrrhizic acid in a murine model of asthma","volume":"21","author":"Wu Q","year":"2016","unstructured":"Wu Q, Tang Y, Hu X, et al.. Regulation of Th1\/Th2 balance through OX40\/OX40L signalling by glycyrrhizic acid in a murine model of asthma. Respirology. 2016, 21:102-111. 10.1111\/resp.12655","journal-title":"Respirology"},{"key":"ref210","doi-asserted-by":"publisher","DOI":"10. 10.3390\/plants10122751","article-title":"Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology","volume":"10","author":"Wahab S","year":"2021","unstructured":"Wahab S, Annadurai S, Abullais SS, et al.. Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology. Plants. 2021, 10:2751. 10. 10.3390\/plants10122751","journal-title":"Plants"},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14393","article-title":"Ginkgo biloba extract protects human melanocytes from H(2) O(2)-induced oxidative stress by activating Nrf2","volume":"23","author":"Zhang S","year":"2019","unstructured":"Zhang S, Yi X, Su X, et al.. Ginkgo biloba extract protects human melanocytes from H(2) O(2)-induced oxidative stress by activating Nrf2. J Cell Mol Med. 2019, 23:5193-5199. 10.1111\/jcmm.14393","journal-title":"J Cell Mol Med"},{"key":"ref212","doi-asserted-by":"publisher","DOI":"10. 10.3390\/life10070106","article-title":"Pharmacokinetic interactions between herbal medicines and drugs: their mechanisms and clinical relevance","volume":"10","author":"Rombola L","year":"2020","unstructured":"Rombola L, Scuteri D, Marilisa S, et al.. Pharmacokinetic interactions between herbal medicines and drugs: their mechanisms and clinical relevance. Life. 2020, 10:106. 10. 10.3390\/life10070106","journal-title":"Life"},{"key":"ref213","doi-asserted-by":"publisher","DOI":"10.1155\/omcl\/3193670","article-title":"An overview of the biological complexity of vitiligo","volume":"2024","author":"Matarrese P","year":"2024","unstructured":"Matarrese P, Puglisi R, Mattia G, Samela T, Abeni D, Malorni W. An overview of the biological complexity of vitiligo. Oxid Med Cell Longev. 2024, 2024:3193670. 10.1155\/omcl\/3193670","journal-title":"Oxid Med Cell Longev"},{"key":"ref214","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001689","article-title":"Pro-pigmentary action of 5-fluorouracil through the stimulated secretion of CXCL12 by dermal fibroblasts","volume":"134","author":"Liao ZK","year":"2021","unstructured":"Liao ZK, Hu SH, Han BY, Qiu X, Jiang S, Lei TC. Pro-pigmentary action of 5-fluorouracil through the stimulated secretion of CXCL12 by dermal fibroblasts. Chin Med J. 2021, 134:2475-2482. 10.1097\/CM9.0000000000001689","journal-title":"Chin Med J"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15741","article-title":"An overview of the role of carboxytherapy in dermatology","volume":"22","author":"Bagherani N","year":"2023","unstructured":"Bagherani N, Smoller BR, Tavoosidana G, Ghanadan A, Wollina U, Lotti T. An overview of the role of carboxytherapy in dermatology. J Cosmet Dermatol. 2023, 22:2399-2407. 10.1111\/jocd.15741","journal-title":"J Cosmet Dermatol"},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.08.020","article-title":"Carboxytherapy in dermatology","volume":"40","author":"Kroumpouzos G","year":"2022","unstructured":"Kroumpouzos G, Arora G, Kassir M, et al.. Carboxytherapy in dermatology. Clin Dermatol. 2022, 40:305-309. 10.1016\/j.clindermatol.2021.08.020","journal-title":"Clin Dermatol"},{"key":"ref217","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/563709","article-title":"Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases","volume":"2012","author":"Rodriguez-Cerdeira C","year":"2012","unstructured":"Rodriguez-Cerdeira C, Sanchez-Blanco E, Molares-Vila A. Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases. Mediators Inflamm. 2012, 2012:563709. 10.1155\/2012\/563709","journal-title":"Mediators Inflamm"},{"key":"ref218","article-title":"Choosing topical corticosteroids","volume":"79","author":"Ference JD","year":"2009","unstructured":"Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009, 79:135-140.","journal-title":"Am Fam Physician"},{"key":"ref219","article-title":"Topical corticosteroids","author":"Gabros S","year":"2023","unstructured":"Gabros S, Nessel TA, Zito PM. Topical corticosteroids. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref220","article-title":"Topical corticosteroids: choice and application","volume":"103","author":"Stacey SK","year":"2021","unstructured":"Stacey SK, McEleney M. Topical corticosteroids: choice and application. Am Fam Physician. 2021, 103:337-343.","journal-title":"Am Fam Physician"},{"key":"ref221","doi-asserted-by":"publisher","DOI":"10.5070\/D329361422","article-title":"Non-psoriatic uses of calcipotriol: a concise updated review","volume":"29","author":"Patel RT","year":"2023","unstructured":"Patel RT, Gay JJ, Fagan KK, Eikenberg JD. Non-psoriatic uses of calcipotriol: a concise updated review. Dermatol Online J. 2023, 29:3. 10.5070\/D329361422","journal-title":"Dermatol Online J"},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700624","article-title":"Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3","volume":"127","author":"Hawker NP","year":"2007","unstructured":"Hawker NP, Pennypacker SD, Chang SM, Bikle DD. Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. J Invest Dermatol. 2007, 127:874-880. 10.1038\/sj.jid.5700624","journal-title":"J Invest Dermatol"},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.408765","article-title":"Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex","volume":"288","author":"Rodriguez G","year":"2013","unstructured":"Rodriguez G, Ross JA, Nagy ZS, Kirken RA. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. J Biol Chem. 2013, 288:7137-7146. 10.1074\/jbc.M112.408765","journal-title":"J Biol Chem"},{"key":"ref224","doi-asserted-by":"publisher","DOI":"10.1007\/s12257-010-0121-0","article-title":"Potential of Cassia alata leaf extract in inducing differentiation and migration of mouse melanoblasts","volume":"15","author":"Babitha S","year":"2010","unstructured":"Babitha S, Nguyen DH, Park S-J, et al.. Potential of Cassia alata leaf extract in inducing differentiation and migration of mouse melanoblasts. Biotechnol Bioprocess Eng. 2010, 15:1071-1076. 10.1007\/s12257-010-0121-0","journal-title":"Biotechnol Bioprocess Eng"},{"key":"ref225","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1113-5","article-title":"Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action","volume":"30","author":"Carillon J","year":"2013","unstructured":"Carillon J, Rouanet JM, Cristol JP, Brion R. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action. Pharm Res. 2013, 30:2718-2728. 10.1007\/s11095-013-1113-5","journal-title":"Pharm Res"},{"key":"ref226","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12950","article-title":"Meta-analysis of the association between vitiligo and the level of superoxide dismutase or malondialdehyde","volume":"42","author":"Shi MH","year":"2017","unstructured":"Shi MH, Wu Y, Li L, et al.. Meta-analysis of the association between vitiligo and the level of superoxide dismutase or malondialdehyde. Clin Exp Dermatol. 2017, 42:21-29. 10.1111\/ced.12950","journal-title":"Clin Exp Dermatol"},{"key":"ref227","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1608586","article-title":"Folic acid protects melanocytes from oxidative stress via activation of Nrf2 and inhibition of HMGB1","volume":"2021","author":"Du P","year":"2021","unstructured":"Du P, Zhang S, Li S, et al.. Folic acid protects melanocytes from oxidative stress via activation of Nrf2 and inhibition of HMGB1. Oxid Med Cell Longev. 2021, 2021:1608586. 10.1155\/2021\/1608586","journal-title":"Oxid Med Cell Longev"},{"key":"ref228","doi-asserted-by":"publisher","DOI":"10.1039\/c9fo00336c","article-title":"Turmeronol A and turmeronol B from curcuma longa prevent inflammatory mediator production by lipopolysaccharide-stimulated RAW264.7 macrophages, partially via reduced NF-kappaB signaling","volume":"10","author":"Okuda-Hanafusa C","year":"2019","unstructured":"Okuda-Hanafusa C, Uchio R, Fuwa A, et al.. Turmeronol A and turmeronol B from curcuma longa prevent inflammatory mediator production by lipopolysaccharide-stimulated RAW264.7 macrophages, partially via reduced NF-kappaB signaling. Food Funct. 2019, 10:5779-5788. 10.1039\/c9fo00336c","journal-title":"Food Funct"},{"key":"ref229","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46110712","article-title":"Identifying herbal candidates and active compounds for psoriasis through multiscale network analysis","volume":"46","author":"Kim GB","year":"2024","unstructured":"Kim GB, Lee SY, Shin SW, et al.. Identifying herbal candidates and active compounds for psoriasis through multiscale network analysis. Curr Issues Mol Biol. 2024, 46:11993-12011. 10.3390\/cimb46110712","journal-title":"Curr Issues Mol Biol"},{"key":"ref230","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01563","article-title":"Treatment with a flavonoid-rich fraction of bergamot juice improved lipopolysaccharide-induced periodontitis in rats","volume":"9","author":"Gugliandolo E","year":"2018","unstructured":"Gugliandolo E, Fusco R, D'Amico R, et al.. Treatment with a flavonoid-rich fraction of bergamot juice improved lipopolysaccharide-induced periodontitis in rats. Front Pharmacol. 2018, 9:1563. 10.3389\/fphar.2018.01563","journal-title":"Front Pharmacol"},{"key":"ref231","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13824","article-title":"Placental extracts regulate melanin synthesis in normal human melanocytes with alterations of mitochondrial respiration","volume":"28","author":"Yoshimoto S","year":"2019","unstructured":"Yoshimoto S, Ohagi Y, Yoshida M, et al.. Placental extracts regulate melanin synthesis in normal human melanocytes with alterations of mitochondrial respiration. Exp Dermatol. 2019, 28:50-54. 10.1111\/exd.13824","journal-title":"Exp Dermatol"},{"key":"ref232","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-017-0309-4","article-title":"Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappaB signaling","volume":"25","author":"Jarosz M","year":"2017","unstructured":"Jarosz M, Olbert M, Wyszogrodzka G, Mlyniec K, Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappaB signaling. Inflammopharmacology. 2017, 25:11-24. 10.1007\/s10787-017-0309-4","journal-title":"Inflammopharmacology"},{"key":"ref233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61982-8","article-title":"Zinc, copper, and selenium levels in vitiligo: a systematic review and meta-analysis","volume":"14","author":"Anam K","year":"2024","unstructured":"Anam K, Ananyan S, Rishabh M, Dinesh A, Ashwin K. Zinc, copper, and selenium levels in vitiligo: a systematic review and meta-analysis. Sci Rep. 2024, 14:23700. 10.1038\/s41598-024-61982-8","journal-title":"Sci Rep"},{"key":"ref234","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08712.x","article-title":"Is there a relationship between homocysteine and vitiligo? A pilot study","volume":"159","author":"Shaker OG","year":"2008","unstructured":"Shaker OG, El-Tahlawi SM. Is there a relationship between homocysteine and vitiligo? A pilot study. Br J Dermatol. 2008, 159:720-724. 10.1111\/j.1365-2133.2008.08712.x","journal-title":"Br J Dermatol"},{"key":"ref235","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63311","article-title":"Reversible hyperpigmentation in a patient with Vitamin B12 deficiency","volume":"16","author":"Yakubu AS","year":"2024","unstructured":"Yakubu AS, Ahadzi D. Reversible hyperpigmentation in a patient with Vitamin B12 deficiency. Cureus. 2024, 16:63311. 10.7759\/cureus.63311","journal-title":"Cureus"},{"key":"ref236","doi-asserted-by":"publisher","DOI":"10.3390\/nu11020482","article-title":"Vitamin B(12) in relation to oxidative stress: a systematic review","volume":"11","author":"van de Lagemaat EE","year":"2019","unstructured":"van de Lagemaat EE, de Groot L, van den Heuvel E. Vitamin B(12) in relation to oxidative stress: a systematic review. Nutrients. 2019, 11:10.3390\/nu11020482","journal-title":"Nutrients"},{"key":"ref237","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113380","article-title":"B Vitamins and their role in immune regulation and cancer","volume":"12","author":"Peterson CT","year":"2020","unstructured":"Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B Vitamins and their role in immune regulation and cancer. Nutrients. 2020, 12:10.3390\/nu12113380","journal-title":"Nutrients"},{"key":"ref238","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16468","article-title":"Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: a systematic review, from mechanisms of action to mono-, combination and comparative therapies","volume":"23","author":"Pourriyahi H","year":"2024","unstructured":"Pourriyahi H, Hosseini NS, Nooshabadi MP, et al.. Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: a systematic review, from mechanisms of action to mono-, combination and comparative therapies. J Cosmet Dermatol. 2024, 23:3466-3487. 10.1111\/jocd.16468","journal-title":"J Cosmet Dermatol"},{"key":"ref239","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.11.1541","article-title":"Bimatoprost-induced periocular skin hyperpigmentation: histopathological study","volume":"123","author":"Kapur R","year":"2005","unstructured":"Kapur R, Osmanovic S, Toyran S, Edward DP. Bimatoprost-induced periocular skin hyperpigmentation: histopathological study. Arch Ophthalmol. 2005, 123:1541-1546. 10.1001\/archopht.123.11.1541","journal-title":"Arch Ophthalmol"},{"key":"ref240","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19127246","article-title":"Tetracyclines-an important therapeutic tool for dermatologists","volume":"19","author":"Orylska-Ratynska M","year":"2022","unstructured":"Orylska-Ratynska M, Placek W, Owczarczyk-Saczonek A. Tetracyclines-an important therapeutic tool for dermatologists. Int J Environ Res Public Health. 2022, 19:7246. 10.3390\/ijerph19127246","journal-title":"Int J Environ Res Public Health"},{"key":"ref241","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001699","article-title":"Trichloroacetic acid 25% peel to facilitate dermabrasion at difficult sites in vitiligo surgery","volume":"45","author":"Razmi TM","year":"2019","unstructured":"Razmi TM, Kumaran SM, Parsad D. Trichloroacetic acid 25% peel to facilitate dermabrasion at difficult sites in vitiligo surgery. Dermatol Surg. 2019, 45:750-752. 10.1097\/DSS.0000000000001699","journal-title":"Dermatol Surg"},{"key":"ref242","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04368.x","article-title":"Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets","volume":"27","author":"El Nasr HS","year":"2013","unstructured":"El Nasr HS, Shaker OG, Fawzi MM, El-Hanafi G. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets. J Eur Acad Dermatol Venereol. 2013, 27:103-108. 10.1111\/j.1468-3083.2011.04368.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref243","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2011.4073","article-title":"Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease","volume":"18","author":"Kesarwani P","year":"2013","unstructured":"Kesarwani P, Murali AK, Al-Khami AA, Mehrotra S. Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal. 2013, 18:1497-1534. 10.1089\/ars.2011.4073","journal-title":"Antioxid Redox Signal"},{"key":"ref244","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15725-7","article-title":"Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression","volume":"7","author":"Lee YS","year":"2017","unstructured":"Lee YS, Lee MH, Kim HJ, Won HR, Kim CH. Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression. Sci Rep. 2017, 7:15564. 10.1038\/s41598-017-15725-7","journal-title":"Sci Rep"},{"key":"ref245","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001551","article-title":"A review of the use of ultrasound for skin tightening, body contouring, and cellulite reduction in dermatology","volume":"44","author":"Juhasz M","year":"2018","unstructured":"Juhasz M, Korta D, Mesinkovska NA. A review of the use of ultrasound for skin tightening, body contouring, and cellulite reduction in dermatology. Dermatol Surg. 2018, 44:949-963. 10.1097\/DSS.0000000000001551","journal-title":"Dermatol Surg"},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003263.pub3","article-title":"Interventions for vitiligo","author":"Whitton ME","year":"2006","unstructured":"Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev. 2006, CD003263. 10.1002\/14651858.CD003263.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref247","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003263.pub4","article-title":"Interventions for vitiligo","author":"Whitton ME","year":"2010","unstructured":"Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev. 2010, CD003263. 10.1002\/14651858.CD003263.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref248","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0696","article-title":"Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis","volume":"155","author":"Lee JH","year":"2019","unstructured":"Lee JH, Kwon HS, Jung HM, et al.. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2019, 155:929-938. 10.1001\/jamadermatol.2019.0696","journal-title":"JAMA Dermatol"},{"key":"ref249","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2071699","article-title":"Efficacy of local prostaglandin analogues for vitiligo treatment: a systematic review and meta-analysis","volume":"15","author":"Chang HC","year":"2022","unstructured":"Chang HC, Guo SP. Efficacy of local prostaglandin analogues for vitiligo treatment: a systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2022, 15:341-349. 10.1080\/17512433.2022.2071699","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref250","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15534","article-title":"Comparison of NB-UVB combination therapy regimens for vitiligo: a systematic review and network meta-analysis","volume":"22","author":"Zhu B","year":"2023","unstructured":"Zhu B, Liu C, Zhang L, Wang J, Chen M, Wei Y. Comparison of NB-UVB combination therapy regimens for vitiligo: a systematic review and network meta-analysis. J Cosmet Dermatol. 2023, 22:1083-1098. 10.1111\/jocd.15534","journal-title":"J Cosmet Dermatol"},{"key":"ref251","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13642","article-title":"A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo","volume":"30","author":"Jafarzadeh A","year":"2024","unstructured":"Jafarzadeh A, Mohammad AP, Khosravi M, et al.. A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. Skin Res Technol. 2024, 30:13642. 10.1111\/srt.13642","journal-title":"Skin Res Technol"},{"key":"ref252","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2020.0292","article-title":"A systematic review of nutrition, supplement, and herbal-based adjunctive therapies for vitiligo","volume":"27","author":"Shakhbazova A","year":"2021","unstructured":"Shakhbazova A, Wu H, Chambers CJ, Sivamani RK. A systematic review of nutrition, supplement, and herbal-based adjunctive therapies for vitiligo. J Altern Complement Med. 2021, 27:294-311. 10.1089\/acm.2020.0292","journal-title":"J Altern Complement Med"},{"key":"ref253","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16660","article-title":"A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo","volume":"24","author":"Jafarzadeh A","year":"2025","unstructured":"Jafarzadeh A, Mohammad AP, Goodarzi A. A systematic review of case series and clinical trials investigating regenerative medicine for the treatment of vitiligo. J Cosmet Dermatol. 2025, 24:16660. 10.1111\/jocd.16660","journal-title":"J Cosmet Dermatol"},{"key":"ref254","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.08.066","article-title":"Systemic Janus kinase inhibitor treatment for vitiligo: an evidence-based review","volume":"92","author":"Sood S","year":"2025","unstructured":"Sood S, Varenbut J, Bagit A, et al.. Systemic Janus kinase inhibitor treatment for vitiligo: an evidence-based review. J Am Acad Dermatol. 2025, 92:135-137. 10.1016\/j.jaad.2024.08.066","journal-title":"J Am Acad Dermatol"},{"key":"ref255","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1735615","article-title":"Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis","volume":"33","author":"Phan K","year":"2022","unstructured":"Phan K, Phan S, Shumack S, Gupta M. Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis. J Dermatol Treat. 2022, 33:173-177. 10.1080\/09546634.2020.1735615","journal-title":"J Dermatol Treat"},{"key":"ref256","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4090","article-title":"Cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: a systematic review and meta-analysis","volume":"160","author":"Ingrassia JP","year":"2024","unstructured":"Ingrassia JP, Maqsood MH, Gelfand JM, et al.. Cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: a systematic review and meta-analysis. JAMA Dermatol. 2024, 160:28-36. 10.1001\/jamadermatol.2023.4090","journal-title":"JAMA Dermatol"},{"key":"ref257","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.5509","article-title":"Short-term cardiovascular complications in dermatology patients receiving JAK-STAT inhibitors: a meta-analysis of randomized clinical trials","volume":"160","author":"Ireland PA","year":"2024","unstructured":"Ireland PA, Jansson N, Spencer SKR, Braden J, Sebaratnam D. Short-term cardiovascular complications in dermatology patients receiving JAK-STAT inhibitors: a meta-analysis of randomized clinical trials. JAMA Dermatol. 2024, 160:281-289. 10.1001\/jamadermatol.2023.5509","journal-title":"JAMA Dermatol"},{"key":"ref258","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac074","article-title":"Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials","volume":"188","author":"Eleftheriadou V","year":"2023","unstructured":"Eleftheriadou V, Bergqvist C, Kechichian E, et al.. Has the core outcome (domain) set for vitiligo been implemented? An updated systematic review on outcomes and outcome measures in vitiligo randomized clinical trials. Br J Dermatol. 2023, 188:247-258. 10.1093\/bjd\/ljac074","journal-title":"Br J Dermatol"},{"key":"ref259","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12354","article-title":"Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus","volume":"28","author":"Eleftheriadou V","year":"2015","unstructured":"Eleftheriadou V, Thomas K, van Geel N, et al.. Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res. 2015, 28:363-369. 10.1111\/pcmr.12354","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref260","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221260","article-title":"Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo","volume":"14","author":"Yang P","year":"2023","unstructured":"Yang P, Luan M, Li W, et al.. Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. Front Immunol. 2023, 14:1221260. 10.3389\/fimmu.2023.1221260","journal-title":"Front Immunol"},{"key":"ref261","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd8995","article-title":"scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T(reg) function","volume":"13","author":"Gellatly KJ","year":"2021","unstructured":"Gellatly KJ, Strassner JP, Essien K, et al.. scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T(reg) function. Sci Transl Med. 2021, 13:8995. 10.1126\/scitranslmed.abd8995","journal-title":"Sci Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439652-a-review-of-randomized-controlled-trials-for-vitiligo-therapies-published-between-2013-and-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:48:38Z","timestamp":1783525718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439652-a-review-of-randomized-controlled-trials-for-vitiligo-therapies-published-between-2013-and-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":261,"URL":"https:\/\/doi.org\/10.7759\/cureus.112280","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}